Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice

Version of Record

Accepted for publication after peer review and revision.

Download
Cite
Share
CommentOpen annotations (there are currently 0 annotations on this page).

Version of Record published: December 20, 2022 (This version)
Accepted: October 31, 2022
Accepted Manuscript published: October 31, 2022 (Go to version)
Received: August 2, 2022
Preprint posted: February 4, 2022 (Go to version)

1. Of interest
An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: A nonrandomized controlled trial

Caigang Liu, Hong Yu ... Yongliang Yang

Research Article Updated Mar 30, 2023
Further reading

Article
Figures and data
Abstract
Editor's evaluation
eLife digest
Introduction
Results
Discussion
Materials and methods
Appendix 1
Data availability
References
Decision letter
Author response
Article and author information
Metrics

Abstract

Stimulator of interferon genes (STING) is activated after detection of cytoplasmic dsDNA by cGAS (cyclic GMP-AMP synthase) as part of the innate immunity defence against viral pathogens. STING binds TANK-binding kinase 1 (TBK1). TBK1 mutations are associated with familial amyotrophic lateral sclerosis, and the STING pathway has been implicated in the pathogenesis of further neurodegenerative diseases. To test whether STING activation is sufficient to induce neurodegeneration, we analysed a mouse model that expresses the constitutively active STING variant N153S. In this model, we focused on dopaminergic neurons, which are particularly sensitive to stress and represent a circumscribed population that can be precisely quantified. In adult mice expressing N153S STING, the number of dopaminergic neurons was smaller than in controls, as was the density of dopaminergic axon terminals and the concentration of dopamine in the striatum. We also observed alpha-synuclein pathology and a lower density of synaptic puncta. Neuroinflammation was quantified by staining astroglia and microglia, by measuring mRNAs, proteins and nuclear translocation of transcription factors. These neuroinflammatory markers were already elevated in juvenile mice although at this age the number of dopaminergic neurons was still unaffected, thus preceding the degeneration of dopaminergic neurons. More neuroinflammatory markers were blunted in mice deficient for inflammasomes than in mice deficient for signalling by type I interferons. Neurodegeneration, however, was blunted in both mice. Collectively, these findings demonstrate that chronic activation of the STING pathway is sufficient to cause degeneration of dopaminergic neurons. Targeting the STING pathway could therefore be beneficial in Parkinson’s disease and further neurodegenerative diseases.

Editor's evaluation

STING has recently been implicated in the pathogenesis of neurodegenerative diseases. In the current work, the authors analysed a mouse model that expresses the constitutively active STING variant N153S and demonstrated that activation of the STING pathway via downstream signalling by type I interferons (Ifnar1-/-) or inflammasome activation (Casp1-/-) is sufficient to induce degeneration of dopaminergic neurons. Moreover, STING activation is sufficient to induce α-synuclein pathology in Parkinson's disease. This finding is of interest to the broad readership of eLife.

https://doi.org/10.7554/eLife.81943.sa0

eLife digest

Neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases are characterised by neurons getting damaged and dying. Many factors contribute to this process, but few can be effectively controlled by therapies. Interestingly, previous studies have highlighted that inflammation, a process normally triggered by foreign agents or biological damage, is often associated with neurons degenerating. However, it is unclear whether these responses are the cause or the consequence of brain cell damage.

In injured neurons, the genetic information normally contained inside a dedicated cellular compartment can start to leak into the surrounding parts of the cell. This damage triggers an inflammatory response through the STING pathway, a mechanism previously implicated in the onset of Parkinson’s disease. In these patients, the neurons that produce the signalling molecule dopamine start to die, leading to difficulty with movement. Whether STING can directly cause this neuronal loss remains unknown.

To answer this question, Szegö, Malz et al. genetically engineered mice in which the STING pathway is permanently activated. The animals had fewer dopamine-producing neurons and accumulated harmful clumps of proteins; both these biological features are characteristic signs of Parkinson’s disease. Crucially, signs of inflammation were present before neurons started to show damage, suggesting that inflammatory responses could cause neurodegeneration. Further experiments revealed that STING triggers several molecular cascades; blocking one only of these pathways did not keep the neurons healthy.

Neurodegenerative diseases are a growing concern around the world. The results from Szegö, Malz et al. suggest that preventing prolonged inflammatory may reduce the risk of neurodegeneration. If further research confirms these findings, in particular in humans, well-known treatments against inflammation could potentially become relevant to fight these conditions.

Introduction

Inflammation is recognized increasingly as a major driver for neurodegenerative diseases, including Parkinson’s disease (PD) (Harms et al., 2021; Hirsch and Standaert, 2021). The stimulator of interferon genes (STING) responds to cytoplasmic dsDNA as part of the innate immunity defence against viral pathogens (Paul et al., 2021). STING is activated by cyclic GMP-AMP (cGAMP) produced by cGAMP synthase (cGAS) upon binding to dsDNA (Motwani et al., 2019). This pathway can be activated by pathogen-derived nucleic acids but also by cytoplasmic self-DNA (Chen et al., 2016; Li and Chen, 2018; Motwani et al., 2019). STING binds TANK-binding kinase 1 (TBK1) and activates the transcription factors interferon regulatory factor 3 (IRF3) (Chen et al., 2021) and nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NF-κB) (Liu et al., 2014). The resulting increased production of type I interferons (IFN) and pro-inflammatory cytokines induce the activation of inflammasomes and inflammation (Hopfner and Hornung, 2020). STING, however, can activate inflammasomes directly (Wang et al., 2020). Inflammasomes are major signalling hubs that activate caspase-1 and control the bioactivity of pro-inflammatory cytokines of the interleukin (IL)–1 family (Gaidt et al., 2017; Schroder and Tschopp, 2010).

The cGAS-STING pathway has been implicated in PD pathogenesis. Mice deficient for the PD-associated proteins PTEN-induced kinase 1 (PINK) and parkin show a STING-mediated inflammatory phenotype after exhaustive exercise (Sliter et al., 2018). This phenotype results from the PINK/parkin-dependent failure to degrade damaged mitochondria and the consecutive accumulation of mitochondrial DNA in the cytosol. Indeed, inflammatory markers like IL-6 were also observed in human patients with parkin mutations (Sliter et al., 2018). Similarly, cytoplasmic accumulation of TDP-43, which constitutes the most common pathological finding in sporadic amyotrophic lateral sclerosis (ALS), triggers the release of mitochondrial DNA and the consecutive, STING-dependent neuroinflammation and neurodegeneration (Yu et al., 2020). In addition, mutations in TBK1 are associated with familial ALS (Freischmidt et al., 2015). Finally, activation of inflammasomes formed by the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) has been linked to the progression of several neurodegenerative diseases (Heneka et al., 2018).

Neuroinflammation receives growing attention in neurodegenerative diseases because it represents a promising therapeutic target. Designing such therapies, however, requires to determine the specific effects of individual components of this highly interconnected signalling network, which responds to diverse stimuli and involves many different cell types. Previous studies have demonstrated that depleting or blocking STING can alleviate neurodegeneration in models of PD (Sliter et al., 2018) and ALS (Yu et al., 2020). To complement these observations and provide a model to study the signalling downstream of STING, we wanted to determine whether specific activation of STING is sufficient to cause neurodegeneration. In order to test this, we used a mouse model with heterozygous expression of the STING genetic variant N153S (Luksch et al., 2019). Constitutively active STING mutants cause an autoinflammatory disease in humans termed STING-associated vasculopathy with onset in infancy (SAVI) (Crow and Casanova, 2014; Liu et al., 2014). SAVI is characterized by systemic inflammation with acral vasculitis, T cell lymphopenia, and interstitial pulmonary disease. Major features of systemic inflammation in SAVI are recapitulated in STING N153S knock-in mice (Luksch et al., 2019; Siedel et al., 2020). For simplicity, we refer to these as STING ki mice here and use the term STING WT for the corresponding wild type littermate controls. In these mice, we determined the extent of neuroinflammation and quantified the integrity of dopaminergic neurons that project from the substantia nigra pars compacta to the striatum. We focused on dopaminergic neurons because they have been the centre of our investigations (Falkenburger et al., 2001; Komnig et al., 2018; Szegö et al., 2022; Szego et al., 2012), and because STING has been implicated in the pathogenesis of PD (Hinkle et al., 2022; Sliter et al., 2018). Furthermore, we measured alpha-synuclein (aSyn) pathology, which constitutes the second neuropathological feature of PD next to the degeneration of dopaminergic neurons. To determine which of the known downstream signalling pathways contribute to STING-induced neurodegeneration, we used mice deficient for type I IFN receptor (Ifnar1) or caspase 1 (Casp1).

Results

Neuroinflammation and degeneration of dopaminergic neurons in mice with constitutive STING activation

To characterize the neuronal phenotype in adult STING ki mice, we assessed neuroinflammation and the integrity of the dopaminergic nigrostriatal system. First, we stained striatal sections for Iba1 to determine the activation of microglia. The Iba1 positive area fraction was 9-fold higher in STING ki mice than in STING WT (Figure 1A and C), accompanied by an 3.8-fold increase in the number of Iba1-positive cells (Figure 1—figure supplement 1A). Activation of astroglia, as determined by GFAP staining, was 26-fold higher in STING ki mice than in STING WT (Figure 1B and D), and the number of astroglial cells increased to 6.7-fold (Figure 1—figure supplement 1B). Similarly, in the substantia nigra (SN), activation of astroglia (Figure 1—figure supplement 1C, F, H) and microglia (Figure 1—figure supplement 1C, G, I) increased as well. Thus, STING ki mice exhibit a strong neuroinflammatory phenotype, consistent with increased systemic inflammation (Luksch et al., 2019).

Figure 1 with 1 supplement see all

Download asset Open asset

Constitutive STING activation induces neuroinflammation and neurodegeneration in adult mice.

(A) Representative images of striatal sections from STING WT and STING ki mice stained for the microglia marker Iba1. Scale bar: 50 μm. (B) Representative images of striatal sections stained for the astroglia marker GFAP. Scale bar: 50 μm. (C) Representative images of midbrain sections containing the substantia nigra (SN) from STING WT and STING ki mice (stitched from two microscopy fields) stained for tyrosine hydroxylase (TH). Scale bar: 100 μm. (D) Representative images of striatal sections stained for TH from STING WT and STING ki mice. Scale bar: 10 μm. (E) Area fraction positive for Iba1, normalized to the mean of STING WT mice. Markers represent individual animals (black: STING WT animals, red: STING ki animals). Lines represent mean ± SD. Comparison by t-test (***: p=0.0007, n=5). Graph showing the counted numbers of Iba1-positive neurons is on Figure 1—figure supplement 1A. (F) Area fraction positive for GFAP, normalized to the mean of STING WT mice (**: p=0.0011; t-test, n=5). Graph showing the counted numbers of GFAP-positive neurons is on Figure 1—figure supplement 1B. (G) Number of TH-positive neurons (*: p=0.0257; t-test, n=5). Graph showing the counted numbers of dopaminergic neurons is on Figure 1—figure supplement 1D. (H) Area fraction positive for TH (**: p=0.0081; t-test, n=5). (I) Concentration of dopamine (*: p=0.0448; t-test, n=5) in striatal lysates from STING WT and STING ki animals, normalized to the mean concentration in STING WT. Graph showing quantification of the dopamine metabolites is in Figure 1—figure supplement 1E.

Next, we asked whether the chronic neuroinflammation in the STING ki mice is associated with the degeneration of dopaminergic neurons. Somata of dopaminergic neurons in the SN (Figure 1E) and dopaminergic axon terminals in the striatum (Figure 1F) were identified by staining for tyrosine hydroxylase (TH). The SN of STING ki mice contained significantly fewer TH-positive neurons than the SN of STING WT (Figure 1G and Figure 1—figure supplement 1D). Similarly, the density of dopaminergic axon terminals (fibers) in the striatum was lower in STING ki mice than in STING WT (Figure 1H). Accordingly, the concentration of dopamine in the striatum was lower in STING ki mice than in STING WT mice (Figure 1I). The concentration of dopamine metabolites was higher in STING ki mice (Figure 1—figure supplement 1E), suggesting increased dopamine turnover in STING ki mice - as commonly observed with degeneration of dopaminergic axon terminals. Taken together, these findings demonstrate that the integrity of nigrostriatal dopaminergic neurons is compromised in STING ki mice.

Neuroinflammation without degeneration of the dopaminergic neurons in juvenile mice with constitutive STING activation

In order to explore whether the compromised integrity of dopaminergic neurons is a consequence of a prolonged neuroinflammation, we next analysed brain sections of juvenile (5-week-old) STING ki and STING WT mice (Figure 2). Microglia was already significantly activated in juvenile STING ki mice. The area fraction of the Iba1 staining was twofold higher in STING ki mice than in STING WT (Figure 2A and E). Similarly, the area fraction of GFAP signal was 14-fold higher in STING ki mice than in STING WT (Figure 2B and F), suggesting activation of astroglia in juvenile STING ki mice. However, the number of TH-positive neurons in the substantia nigra was not different between juvenile STING ki mice and STING WT (Figure 2C and G and Figure 2—figure supplement 1A). Similarly, striatal axon terminals (Figure 2D and H) and the concentrations of striatal dopamine and its metabolites (Figure 2I, and Figure 2—figure supplement 1B) were not different between STING ki mice and STING WT.

Figure 2 with 1 supplement see all

Download asset Open asset

Neuroinflammation without neurodegeneration in juvenile mice with constitutive STING activation.

(A) Representative images of striatal sections stained for the microglia marker Iba1 from 5-week-old STING WT and STING ki mice. Scale bar: 50 μm (B) Representative images of striatal sections stained for the astroglia marker GFAP from 5-week-old STING WT and STING ki mice. Scale bar: 50 μm (C) Representative images of midbrain sections containing the substantia nigra (SN, stitched from two microscopy fields) stained for tyrosine hydroxylase (TH) from 5-week-old STING WT and STING ki mice. Scale bar: 100 μm (D) Representative images of striatal sections stained for TH from 5-week-old STING WT and STING ki mice. Scale bar: 10 μm. (E) Area fraction positive for Iba1, normalized to the mean of STING WT (***: p=0,0009; t-test, n=5–6). (F) Area fraction positive for GFAP, normalized to the mean of STING WT brains (***: p=0.0007; t-test, n=5–6). (G) Number of TH-positive neurons (mean ± SD; t-test). Graph showing the counted numbers of dopaminergic neurons is on Figure 2—figure supplement 1A. (H) Area fraction positive for TH (mean ± SD, t-test, n=5–6). (I) Dopamine concentration in striatal lysates from 5-week-old STING WT and STING ki mice, measured by HPLC and normalized to the mean of STING WT (mean ± SD, t-test, n=5–6). Dopamine metabolites are in Figure 2—figure supplement 1B.

Taken together, these findings demonstrate that the compromised integrity of the nigrostriatal system in adult STING ki mice (Figure 1) represents an adult-onset neurodegeneration and not a developmental defect. Given that activation of microglia and astroglia in STING ki mice precedes degeneration of dopaminergic neurons, STING-induced neuroinflammation could contribute to the neurodegeneration.

aSyn pathology and synaptic defects in the striatum of STING ki mice

In PD, degeneration of dopaminergic neurons is associated with aSyn pathology. We therefore analysed aSyn pathology in the striatum and in the SN of STING ki mice. First, we measured the amount of aSyn protein phosphorylated at serine 129 (paSyn), which is considered one of the major pathological forms of aSyn (Anderson et al., 2006; Fujiwara et al., 2002; Samuel et al., 2016). Both striatal and nigral lysates of adult STING ki mice contained a substantial amount of paSyn (Figure 3A and B), which was barely detectable in STING WT. The amount of total aSyn was lower in STING ki mice in both brain regions (Figure 3—figure supplement 1) and the ratio of paSyn to total aSyn increased in STING ki mice (Figure 3B) – as commonly observed in synucleinopathy models and PD patients (Anderson et al., 2006; Chatterjee et al., 2020; Fujiwara et al., 2002; Szegö et al., 2022). To further characterize aSyn pathology in STING ki mice, we assayed the Triton X-100 solubility of αSyn in lysates prepared from the striatum or from the SN (Figure 3C). In lysates prepared from STING ki animals, αSyn was detected both in the Triton X-100 insoluble fraction (Figure 3C upper panel) and in the Triton X-100 soluble fraction (Figure 3C lower panel). In lysates prepared from STING WT animals, αSyn was barely detectable in the Triton X-100 insoluble fraction. Consequently, the ratio of insoluble to soluble aSyn was strongly increased in STING ki mice (Figure 3D).

Figure 3 with 1 supplement see all

Download asset Open asset

Constitutive STING activation induces alpha-synuclein pathology and synapse loss in adult mice.

(A) Representative western blot images showing phosphorylated alpha-synuclein (S129; paSyn) and the loading control βIII-tubulin detected from the substantia nigra (upper panel) and striatum (lower panel). Total levels of aSyn detected from the same membranes are shown on Figure 3—figure supplement 1A, B. (B) Ratio of paSyn and total aSyn signals, expressed as relative to the mean of STING WT (substantia nigra (SN): p=0.000065; striatum: p=0.019; t-test, n=5). (C) Representative western blot images showing aSyn and βIII-tubulin detected from the Triton X-100 insoluble (upper panel) and soluble (lower panel) fractions prepared from the substantia nigra or from the striatum. (D) Ratio of aSyn signals detected in the Triton X-100 soluble and insoluble fractions, expressed as relative to the mean of STING ki (substantia nigra (SN): p=0.00001; striatum: p<0.00001; t-test, n=6). (E) Representative images of striatal sections from 20-week-old STING WT and STING ki mice stained with Thioflavin S (magenta) and nuclear sdye (blue) on the composite images, and ThioS BW. Scale bar: 20 μm. (F) Number of cells with inclusions positive for Thioflavin S (ThioS) per mm² (*: p=0.0141; t-test, n=5). (G) Representative images of striatal sections from 20-week-old STING WT and STING ki mice stained for the presynaptic marker synapsin (upper panel) or for the post-synaptic marker homer (lower panel). Scale bar: 10 μm. (**H–I**) Area fraction positive for synapsin (H, p=0.0053) or homer (I, p=0.0408) (mean ± SD; t-test, n=5).

As an alternative approach to detect aggregated proteins, we used Thioflavin S (ThioS), which binds to the characteristic β-sheet conformation of amyloid-containing proteins, including aSyn (Froula et al., 2019; Neumann et al., 2002). The number of cells with ThioS-positive inclusions was higher in the striatum of adult STING ki mice than in STING WT (Figure 3E and F), consistent with the findings from the aSyn immunoblots (Figure 3A and B).

Since dopamine depletion and aSyn pathology can compromise synaptic integrity, we next quantified the density of synapses in the striatum. Presynaptic puncta were detected by staining against synapsin; post-synaptic puncta were detected by staining against homer (Figure 3G–I). The density of synapsin puncta was 18% lower in adult STING ki than in STING WT (Figure 3H), the density of post-synaptic puncta was 9% lower in STING ki than in STING WT mice (Figure 3I). In summary, we observed aSyn pathology in the striatum and in the SN, and a reduced density of synapses in the striatum of adult STING ki mice.

Type I IFN signalling and NF-κB and inflammasome-dependent signalling are activated in the brain of STING ki mice

In order to analyse the signalling pathways by which constitutively active STING causes degradation of dopaminergic neurons and aSyn pathology, we examined the expression of selected interferon-stimulated genes (ISGs) by quantitative real time PCR in the SN and in the striatum of adult STING ki and STING WT mice (Figure 4). Expression of the interferon-induced protein 44 (Ifi44, Figure 4A and G) and the interferon-induced GTP-binding protein Mx1 (Figure 4B and H) was higher in the striatum of STING ki mice (Figure 4G and H); this difference was not statistically significant in the SN (Figure 4A and B). Similarly, expression of Sting1 was increased in the striatum of STING ki mice, but not in the SN (Figure 4C, I).

Figure 4 with 1 supplement see all

Download asset Open asset

Activation of IFN and NF-κB/inflammasome related genes in the striatum and SN of STING ki mice.

(**A–C**) Expression of ISGs in the substantia nigra of STING WT and STING ki mice. (A) *Iﬁ44* (p=0.1552, n=4–5), (B) *Mx1* (Mann Whitney test, p=0.9048, n=4–5), (C) *Sting1* (P=0.9184, n=4–5). (**D–F**) Expression of NF-κB/inflammasome related genes in the substantia nigra of STING WT and STING ki mice. (D) *Tnfa* (p=0.0691, n=4–5), (E) *Il1b* (Mann Whitney test, *: p=0.0159, n=4–5), (F) *Casp1* (**: p=0.0018, n=4–5). (**G–L**) Expression of ISGs in the striatum of STING WT and STING ki mice. (G) *Iﬁ44* (**: p=0.0078, n=3–4), (H) *Mx1* (*: p=0.0183, n=3–4), (I) *Sting1* (*: p=0.024, n=3–4). (**J–L**) Expression of NF-κB/inflammasome related genes in the striatum of STING WT and STING ki mice. (J) *Tnfa* (n=3–4), (K) *Il1b* (*: p=0.0397, n=3–4), (L) *Casp1* (**: p=0.0017, n=3–5). Markers represent individual animals, bars represent mean ± SD. Analysis was t-test, if not indicated otherwise.

cGAS/STING activation also leads to the activation of the NF-κB and inflammasome pathways (Balka et al., 2020; Balka and De Nardo, 2021; Wang et al., 2020). We therefore analysed induction of the NF-κB and inflammasome pathways by quantitative real time PCR of the downstream mediators, tumour necrosis factor alpha (Tnfa), interleukin 1 beta (Il1b), and caspase-1 (Casp1). The average expression of Tnfa was higher in STING ki mice compared to STING WT mice, but the difference was not statistically significant (Figure 4D and J). In contrast, expression Il1b and Casp1 was significantly higher both in SN and in striatum (Figure 4E, F, K and L). Upregulation of inflammatory mediators was also observed in juvenile mice and in cortical lysates (Figure 4—figure supplement 1). Collectively, these findings are consistent with differential activation of IFN-dependent and IFN independent signalling between brain regions, but further work will be needed to confirm this.

Pro-inflammatory transcription factors translocate to the nucleus in STING ki mice

Nuclear trafficking is critical for the function of transcription factors such as STAT3 and NF-κB (Balka and De Nardo, 2021; Noguchi et al., 2013). To confirm the activation of the type I IFN and NF-κB-dependent pathways in STING ki mice by another method, we therefore quantified the number of nuclei positive for phosphorylated STAT3 (pSTAT3, Figure 5A and C) and for the NF-κB p65 subunit (Figure 5B and D) in the striatum of juvenile and adult mice. There were only very few pSTAT3-positive nuclei in juvenile and adult STING WT mice (Figure 5A). In juvenile STING ki mice, the average number of pSTAT3-positive nuclei was fourfold higher than in juvenile STING WT mice (Figure 5C, p=0.05678, twoway ANOVA). In adult STING ki mice, the number of pSTAT3-positive nuclei was 15-fold higher than in adult STING WT (p=0.00004). The number of NF-κB-positive nuclei was threefold higher in juvenile STING ki mice than in juvenile STING WT (Figure 5B and, p=0.009). In adult STING ki mice, the number of NF-kB-positive nuclei was sixfold higher than in adult STING WT (Figure 5D, p=0.007). Since many of the pSTAT3-positive nuclei were negative for both Iba1 and GFAP (Figure 5A), we next stained striatal sections for the neuronal marker NeuN to determine whether the pSTAT3-positive nuclei are neurons (Figure 5—figure supplement 1A, B). Indeed, 67% of NeuN-positive neurons were also positive for pSTAT3 in STING ki animals and only 1% in STING WT (Figure 5—figure supplement 1B). In fact, neuronal nuclei represent the majority of nuclear pSTAT3 signal (85% in STING WT and 95% in STING ki, Figure 5—figure supplement 1C).

Figure 5 with 1 supplement see all

Download asset Open asset

Nuclear translocation of pSTAT3 and NF-κB in the striatum of 5-week-old and 20 week-old STING WT and STING ki mice.

(A) Representative images of striatal sections from 5-week-old (upper images) and 20-week-old (lower images) STING WT and STING ki mice stained for Iba1 (green), GFAP (white) and phosphorylated-STAT3 (pSTAT3; red). Images show color coded merged channels (center) and in addition pSTAT3 staining in grayscale (left and right). Scale bar: 10 μm. (B) Representative images of striatal sections from 5-week-old (upper images) and 20 week-old (lower images) STING WT and STING ki mice stained for Iba1 (green), GFAP (white), and NF-κB (red). NF-kB staining is shown in grey in separate images. Scale bar: 10 μm. (C) Number of pSTAT3-positive nuclei/mm³ (***: p=0.00004; **: p=0.0025 for the interaction; two-way ANOVA, Bonferroni post-hoc test, n=5). (D) Number of NF-kB-positive nuclei/mm³ (**: p=0.009; ***: p=0.0007; mean ± SD; two-way ANOVA, Bonferroni post-hoc test, n=5).

Taken together, our results show nuclear translocation of pSTAT3 and NF-κB in the striatum of STING ki mice, consistent with a robust activation of type I IFN and NF-κB signalling in STING ki mice.

We next assessed nuclear translocation of interferon regulatory factor 3 (IRF3) in striatal lysates obtained from adult STING WT and STING ki mice using subcellular fractionation (Figure 6A and Figure 6—figure supplement 1). Proper separation of cytosol and nuclei was confirmed by observing HDAC6 exclusively in the nuclear fraction and GAPDH exclusively in the cytosolic fraction. IRF3 was mainly found in the cytosolic fraction of STING WT lysates, but mainly in the nuclear fraction of STING ki lysates (quantified in Figure 6B and Figure 6—figure supplement 1D). This finding suggests that IRF3 translocates to the nucleus in STING ki mice, similar to pSTAT3 and NF-κB (Figure 5). Furthermore, we investigated the contribution of the type I IFN and inflammasome signaling pathways to neuroinflammation in STING ki mice. In order to test the involvement of the IFN dependent pathway, we crossed STING ki mice with mice deficient for type I IFN receptor (Ifnar1^-/-); in order to test the involvement of the inflammasome pathway, we crossed STING ki mice with mice deficient for caspase-1 (Casp1^-/-). Nuclear translocation of IRF3 in STING ki mice was preserved in animals deficient for type I IFN receptor (Ifnar1^-/-), consistent with the notion that IFN signal downstream of IRF3. IRF3 translocation was also preserved in mice deficient for caspase-1 (Casp1^-/-).

Figure 6 with 1 supplement see all

Download asset Open asset

Activation of IRF3 and NF-kB-related signalling pathways in double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.

(A) Representative western blot images showing interferon regulatory factor 3 (IRF3, upper panel), the nuclear marker histone deacetylase 1 (HDAC1, middle panel) and cytoplasmic marker glycerinaldehyd-3-phosphat-dehydrogenase (GAPDH, lower panel) detected from the striatum. Images of the whole membrane stained for the different proteins are shown on Figure 6—figure supplement 1A-C. (B) Ratio of IRF3 and HDAC1, expressed as relative to the mean of STING WT (****: p<0.00001; **: p=0.0043; two-way ANOVA with Tukey post-hoc test, n=4). Ratio of IRF3 and GAPDH expressed as relative to the mean of STING WT is shown on Figure 6—figure supplement 1D. (C) Representative western blot images showing NLR family pyrin domain containing 3 (NLRP3, upper panel), Il1b and pro-Il1b (middle panel) and the loading control βIII tubulin (lower panel) detected from the striatum. Images of the whole membrane stained for the different proteins are shown on Figure 6—figure supplement 1E-H. (D) Ratio of NLRP3 and βIII tubulin, expressed as relative to the mean of STING WT (**: p<0.0057; **: p=0.0029; two-way ANOVA with Tukey post-hoc test, n=4). (E) Ratio of Il1b and pro-Il1b, expressed as relative to the mean of STING WT (****: p<0.00001; two-way ANOVA with Tukey post-hoc test, n=4). (F) Representative images of striatal sections stained for the astroglia marker GFAP (green), microglia marker Iba1 (magenta), apoptosis-associated speck-like protein (ASC, cyan) and Hoechst (blue) from STING WT or STING ki mice on a background of interferon a receptor knockout (*Ifnar1^-/-*), caspase-1 knockout (*Casp1^-/-*) or *Ifnar1^+/+*, *Casp1^+/+* (Ctrl.). Scale bar: 20 μm. Magnified insets show Iba1 and ASC, cyan arrowheads indicate ASC specks. (G) Area fraction of ASC signal within microglia as relative to the mean of STING WT (****: p<0.00001; two-way ANOVA with Tukey post-hoc test, n=4–5). (H) Number of ASC-positive dots within microglia as relative to the mean of STING WT (****: p<0.00001; two-way ANOVA with Tukey post-hoc test, n=4–5). (I) Number of ASC-positive dots within astroglia as relative to the mean of STING WT (**: p=0.0083; ***: p=0.0006; two-way ANOVA with Tukey post-hoc test, n=4–5). Graph showing area fraction of ASC signal within astroglia is on Figure 6—figure supplement 1I.

Inflammasomes are activated in STING ki mice

In order to determine whether inflammasomes are activated in STING ki mice, we first measured the abundance of NLRP3 protein in striatal lysates (Figure 6C, quantified in D, and Figure 6—figure supplement 1F). NLRP3 immunoreactivity was higher in lysates of STING ki mice than in STING WT. This difference was preserved in Ifnar1^-/- mice, but lost in Casp1^-/- mice, consistent with the fact that formation of inflammasomes results in caspase-1 activation followed by Il1b release. Inflammasome formation in mice requires priming via NF-κB to induce expression of the scaffold protein NLRP3 (Bauernfeind et al., 2009; Broz and Dixit, 2016). This priming is reduced in Casp1^-/- mice due to the reduction of Il1b cleavage and release and, hence, less NF-κB activation. In addition, cleavage of pro-Il1b was activated in STING ki mice as compared to STING WT (Figure 6C, quantified in E, and Figure 6—figure supplement 1F). This difference was preserved in Ifnar1^-/- mice, but lost in Casp1^-/- mice, consistent with the fact that pro-Il1b cleavage is mediated by caspase-1.

To confirm that inflammasomes are activated in STING ki mice, we stained for the inflammasome scaffold apoptosis-associated speck-like protein containing a CARD (ASC). ASC-positive puncta were observed in Iba1-positive and in GFAP-positive cells of striatal slices (Figure 6F). Both the area fraction of ASC staining (Figure 6G) and the number of puncta within Iba1-positive cells (Figure 6H) was higher in slices of adult STING ki mice than in STING WT. ASC-positive dots were also observed in GFAP-positive cells, but not as frequently as in Iba1-positive cells (Figure 6I and Figure 6—figure supplement 1I). This is consistent with the higher mean intensity of the total ASC signal observed in Iba1-positive cells compared to GFAP-positive cells (Figure 6—figure supplement 1J). Inflammasome activation, as reported by ASC staining, was preserved in Ifnar1^-/- mice but absent in Casp1^-/- mice (Figure 6G–I), consistent with the findings obtained using immunoblots (Figure 6C–E).

Type I IFN and inflammasome signaling contribute to neuroinflammation in STING ki mice

To further explore the interaction between inflammatory pathways for neuroinflammation in our STING ki mice, we measured the expression of ISGs, microglia-polarization related genes and concentrations of 13 cytokines and chemokines (summarized in Figure 7A). For practical reasons, ISG expression was measured in cortical lysates (Figure 7—figure supplement 1) whereas cytokines and genes related to microglia polarisation were measured in striatal lysates (Figure 7—figure supplement 2). The N153S STING-induced increase in the interferon dependent genes Ifi44 and Mx1 was abrogated in Ifnar1^-/- mice, but unaltered in Casp1^-/- mice (Figure 7—figure supplement 1A, B), consistent with the dependence of Ifi44 and Mx1 on type I interferon signalling. Conversely, the N153S STING-induced increase in expression of Il1b was reduced in Casp1^-/- mice, but not in Ifnar1^-/- mice (Figure 7—figure supplement 1C), consistent with the fact that Il1b expression is inflammasome-dependent. The N153S STING-induced increase in Cxcl10 expression was present on all backgrounds (Figure 7—figure supplement 1D). Expression of Tnfa and Sting1 was not different between STING ki and STING WT in adult mice (Figure 7—figure supplement 1E, F).

Figure 7 with 2 supplements see all

Download asset Open asset

Neuroinflammation in adult double transgenic mice with STING ki and knock-out for Ifnar1 or Caspase-1.

(A) Heatmap showing z-scores of different inflammatory markers in double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1. Graphs with data for each mediator individually are on (Figure 7—figure supplement 2). (B) Representative images of striatal sections stained for the microglia marker Iba1. Sections were obtained from adult STING WT (upper images) or STING ki (lower images) mice on a background of interferon a receptor knockout (*Ifnar1^-/-*), caspase-1 knockout (*Casp1^-/-*) or *Ifnar1^+/+*, *Casp1^+/+* (Ctrl.). Scale bar: 50 μm. (C) Representative images of striatal sections stained for the astroglia marker GFAP from STING WT (upper images) or STING ki (lower images) mice on a background of interferon a receptor knockout (*Ifnar1^-/-*), caspase-1 knockout (*Casp1^-/-*) or *Ifnar1^+/+*, *Casp1^+/+* (Ctrl.). Scale bar: 50 μm. (D) Area fraction positive for Iba1, normalized to the mean of STING WT brains (differences in ^+/+ mice ***: p=0.0000001; for *Ifnar1^-/-* ***: p=0.000003; for *Casp1^-/-* ***: p=0.0029374; two-way ANOVA with Bonferroni post-hoc test, n=5–6). (E) Area fraction positive for GFAP, normalized to STING WT on Ctrl. Background (***: p=0.0000 for STING WT vs STING ki on Ctrl.; ***: p=0.0000 on *Ifnar1^-/-*; background, ***: p=0.0006 on Casp1-/- background; two-way ANOVA with Bonferroni post-hoc test, n=5–6).

Activated microglia can exert a continuum of phenotypes between the pro-inflammatory ‘M1’ phenotype and an ‘M2’ phenotype associated with trophic factors and tissue repair (Keren-Shaul et al., 2017; Orihuela et al., 2016). We therefore characterized the effect of STING ki on microglia activation – with and without depletion of Ifnar1 or Casp1 – in striatal lysates (Figure 7—figure supplement 2). For most cytokines, the concentration was higher in lysates of STING ki mice (Figure 7A). When analysed individually, the N153S STING-induced increase was more pronounced in Ifnar1^-/- mice, notably for the ‘M1’ markers IFNα, IFNγ, Cxcl9, Cxcl10, CCL3, and CCL2 (Figure 7—figure supplement 2A-F). The concentration of TNFα protein was unaltered (Figure 7—figure supplement 2G), consistent with the unaltered gene expression (Figure 7—figure supplement 1E). Also, we did not observe a significant difference between STING ki and STING WT for IL-6, CCL4, Il4, IL-10, GM-CSF and VEGF (Figure 7—figure supplement 2H-M). As for gene expression in the striatum, on the Ifnar1^-/- background, both the ‘M1’ marker Nos2 and the ‘M2’ marker Ym-1 were higher in STING ki mice than in STING WT (Figure 7—figure supplement 2N, O). On WT background and in Casp1^-/-mice, the differences between STING ki and STING WT were not statistically significant, similar to the observations with the protein levels of cytokines. Expression of the ‘M2’ markers Il4 and Retnlb was not altered (Figure 7—figure supplement 2P, Q).

A principal component analysis of all measured parameters (Figure 7—figure supplement 2R) shows STING ki as the main contributor of the first component and the WT background as the main contributor of the second component. A heatmap of z-transformed values for all parameters (Figure 7A) shows a marked difference between STING ki and STING WT animals on WT background and in Ifnar1^-/- mice but not in Casp1^-/- mice.

Collectively, these findings suggest a more prominent role for the caspase-1 dependent inflammasome pathway for the N153S STING-dependent activation of the inflammatory mediators we measured. In order to determine functional significance for neuroinflammation, we next measured glial activation in Ifnar1^-/- and Casp1^-/- mice (Figure 7B and C).

For microglia, N153S STING-induced activation of microglia was still observed in adult Ifnar1^-/- and Casp1^-/- mice (Figure 7B and D, fold increase and p values in legend). In order to determine whether the extent of N153S STING-induced microglia activation was significantly different between Ifnar1^-/- mice and Ctrl., we calculated the interaction between the factors ‘STING genotype’ and ‘Ifnar1 genotype’ in two-way ANOVA. The extent of microglia activation was significantly smaller in adult Ifnar1^-/- mice (p=0.004724) than in Ctrl. Similarly, the extent of N153S STING-induced microglia activation was significantly smaller in Casp1^-/- mice (p=0.000021). Furthermore, the extent of N153S STING-induced microglia activation did not differ between Ifnar1^-/- and Casp1^-/- (p=0.0805731). N153S STING-induced microglia activation therefore depends both on type 1 IFN signalling and on inflammasome signalling.

For astroglia (Figure 7C and E), the extent of N153S STING-induced activation was significantly reduced from 26-fold in Ctrl. to 16-fold in Ifnar1^-/- (p=0.0158378 for interaction of twoway ANOVA) and to fourfold in Casp1^-/- (p<0.00001 for interaction of twoway ANOVA). In fact, no statistically significant N153S STING-induced activation of astroglia was observed on the Casp1^-/- background. These findings suggest that astroglia activation might depend more on inflammasome signalling than on type I IFN-dependent signalling.

Oxidative stress in STING ki mice

Neuroinflammation can be associated with oxidative stress, and dopaminergic neurons are particularly sensitive to oxidative stress. We therefore measured reactive oxygen species (ROS) in lysates obtained from the striatum of adult mice. Mitochondrial ROS levels were higher in STING ki than in STING WT (Figure 8A). Similarly, cytoplasmatic ROS levels were increased in STING ki as compared to STING WT (Figure 8B). The N153S STING-induced increase was also observed on the Ifnar1^-/- background, but not on the Casp1^-/- background. To report the activity of the (inducible) nitric oxide synthase, we measured the concentration of nitrite in the striatal lysates (Figure 8C). As for ROS, the nitrite concentration was higher in lysates of STING ki mice than in STING WT; this difference was also observed on Ifnar1^-/- and Casp1^-/- background.

Figure 8

Download asset Open asset

Oxidative stress in the striatum of double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.

(A) Mitochondrial reactive oxygen species (ROS) of striatal lysates determined using MitoSOX and expressed relative to the mean of STING WT (**: p=0.0072; ****: p<0.00001; two-way ANOVA with Tukey post-hoc test, n=4). (B) Cytoplasmic ROS of striatal lysates determined using DCFH-DA and expressed relative to the mean of STING WT (****: p<0.00001; *: p=0,034; **: p=0.0069; two-way ANOVA with Tukey post-hoc test, n=4). (C) Nitrite levels as markers of nitric oxide activity measured in striatal lysates (****: p<0.00001; **: p=0.0052; two-way ANOVA with Tukey post-hoc test, n=4–5).

Taken together, these findings demonstrate increased oxidative stress in the brain of STING ki mice, which constitutes a potential mechanism by which neuroinflammation might contribute to the degeneration of dopaminergic neurons (Figure 1).

Type I IFN and inflammasome signalling contribute to neurodegeneration in STING ki mice

Overall, several parameters of neuroinflammation were blunted in Casp 1 ^/- mice, but not in Ifnar1^-/- mice. We wanted to use this difference to examine the question whether activation of type I IFNs or inflammasomes is more important for degeneration of dopaminergic neurons (Figure 9.). Unfortunately, however, the density of dopaminergic axon terminals in the striatum was already lower in Ifnar1^-/- mice and Casp 1 ^/- mice with WT STING than in control Ifnar1^+/+ and Casp1^+/+ mice (p=0.0143071 and p=0.0000248, two-way ANOVA). These findings suggest that Ifnar1 and Casp1 are required for proper proliferation, maturation and/or maintenance of dopaminergic neurons and their axon terminals. Indeed, the Wnt-β-catenin pathway is regulated by interferons (Kovács et al., 2019) and regulates the differentiation of midbrain dopaminergic neurons (Szegő et al., 2017). Furthermore, Il1b induces the differentiation of dopaminergic neurons (Ling et al., 1998; Rodriguez-Pallares et al., 2005). We found marginally reduced Il1b expression in adult Casp1^-/- mice (Figure 7—figure supplement 1C, STING WT), which could explain reduced density of dopaminergic fibers observed in Casp1^-/- mice.

Figure 9 with 1 supplement see all

Download asset Open asset

Degeneration of dopaminergic neurons in double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.

(A) Representative images of striatal sections stained for tyrosine hydroxylase (TH) from STING WT (upper images) or STING ki (lower images) mice on a background of interferon a receptor knockout (*Ifnar1^-/-*), caspase-1 knockout (*Casp1^-/-*) or *Ifnar1^+/+*, *Casp1^+/+* (Ctrl.). Scale bar: 10 μm. (B) Area fraction positive for TH, normalized to STING WT on Ctrl. background (***: p=0.0000 for Ctrl. background; *: p=0.043 for *Ifnar1^-/-*; **: p=0.0126845 for *Casp1^-/-*; for interaction between Ctrl. background and *Ifnar1^-/-*: p=0.00157; between Ctrl. and *Casp1^-/-*: p=0.007326; two-way ANOVA with Bonferroni post-hoc test, n=5–6). (C) Concentration of dopamine in striatal lysates of STING WT and STING ki mice, normalized to STING WT on Ctrl. background. (***: p=0.0005; t-test, n=5–6). Dopamine metabolism is shown on Figure 9—figure supplement 1.

Both in Ifnar1^-/- and in Casp 1 ^/- mice, the N153S STING-induced degeneration of dopaminergic axon terminals in the striatum was less pronounced than in the control Ifnar1^+/+- and Casp1^+/+ mice (Figure 9A and B; p=0.00157 and p=0.007326 for interaction in two-way ANOVA). N153S STING-induced fibre loss was not statistically different between Ifnar1^-/- and Casp1^-/- mice (p=0.468 for interaction). Consistent with the less pronounced degeneration of dopaminergic axon terminals, the N153S STING-induced reduction in striatal dopamine was not observed in Ifnar1^-/- and Casp1^-/- mice (Figure 9C and Figure 9—figure supplement 1). These findings suggest that both pathways contribute to the degeneration of dopaminergic axon terminals, and blocking either pathway could reduce neurodegeneration.

Discussion

In this work, we demonstrated that the expression of the constitutively active STING variant N153S causes neuroinflammation, which is followed by degeneration of dopaminergic neurons and aSyn pathology. N153S STING-induced microglia activation and degeneration of dopaminergic neurons involve type I IFN and inflammasome-mediated signalling; astroglia activation might depend predominantly on the inflammasome pathway.

Constitutive STING activation causes neuroinflammation

STING is expressed in the central nervous system. Its expression is highest in microglia, but it can also be detected in astroglia and neurons (Jeffries and Marriott, 2017). Microglia are the primary immune cells of the central nervous system (Wolf et al., 2017) and highly activated upon pathogen invasion or tissue damage. Microglia activation in juvenile (Figure 2) and adult (Figure 1) STING ki mice is therefore in line with the increased inflammatory phenotype found in the lungs and spleen of STING ki mice (Luksch et al., 2019; Siedel et al., 2020) and in patients with STING-associated vasculopathy with onset in infancy syndrome (Liu et al., 2014). SAVI patients may suffer from various neurological symptoms, including calcification of basal ganglia, but neurological symptoms are not a core feature of the human SAVI disease (Frémond et al., 2021).

Consistent with this morphologically defined neuroinflammatory phenotype, we observed increased expression of the ISGs Ifi44 and Mx1 in striatum and cortex (Figure 4G and H and supplement 1A, B). Moreover, we observed nuclear translocation of pSTAT3, which was already present in juvenile mice, but more prominent in adult mice (Figure 5C), and nuclear translocation of IRF3 (Figure 6A and B). These effects are associated with IFN signalling, the main pathway downstream of STING (Decout et al., 2021), and demonstrate that expressing the N153S mutant of STING indeed activates IFN-dependent pathways in these brain regions. Accordingly, microglia activation was reduced when N153S STING was expressed in mice deficient for Ifnar1 (Ifnar1^-/-, Figure 7D), confirming that the type I IFN pathway is involved in STING-dependent microglia activation - as previously demonstrated by others (Warner et al., 2017). However, microglia activation by N153S STING was not completely blocked in Ifnar1^-/- mice, suggesting that additional pathways are involved.

Indeed, next to type I IFN signalling, we also observed nuclear translocation of NF-κB (Figure 5D), which was already prominent in juvenile mice, and suggests activation of NF-κB-dependend signalling in STING ki mice. Additionally, we observed increased expression of the NF-κB target genes Il1b (Hiscott et al., 1993) and Tnfa (Collart et al., 1990). Expression of Il1b was significantly increased in lysates of SN (Figure 4E), striatum (Figure 4K) and cortex (Figure 4—figure supplement 1F). For Tnfa, we observed a significant increase in juvenile STING ki (Figure 4—figure supplement 1E), but no significant change in adult mice (Figure 4D and J). Activation of the NF-κB pathway by STING is consistent with previous work by others (Yum et al., 2021). Furthermore, increased expression of Il1b and Tnfa in a mouse model of TDP-43 proteinopathy was recently found to be STING dependent (Yu et al., 2020).

One of the key signalling events downstream of STING and NF-κB is the activation of inflammasomes. Formation and activation of inflammasomes in STING ki mice was observed morphologically by quantification of ASC puncta (Figure 6F–I) and biochemically through Il1b cleavage (Figure 6C and E) and accumulation of NLRP3 (Figure 6C and D). Accordingly, the inflammasome dependent cleavage of Il1b was absent in STING ki mice with Casp1 depletion (Figure 6C and F). The increased abundance of NLRP3 in STING ki mice was not observed in Casp1^-/- mice (Figure 6D), suggesting that this regulation, too, results from inflammasome activation and not directly from NF-κB signalling. Inflammasome activation is consistent with previous work about systemic inflammation (Luksch et al., 2019). The extent of microglia activation by N153S STING was reduced in Casp1^-/- mice (Figure 7D). Therefore, our results suggest that STING-dependent microglia activation involves inflammasome activation, in addition to type I IFN-dependent pathways. Activation of astroglia, in contrast, was completely blocked in Casp1^-/- mice (Figure 7E), suggesting that STING-induced astroglia activation might depend mainly on inflammasome signalling. Mechanistically, astroglia activation could result directly from the expression of N153S STING in astroglia, but also indirectly through the activation of microglia (Kwon and Koh, 2020; Wolf et al., 2017). The differential effect in Ifnar1^-/- and Casp1^-/- mice suggests, however, that astroglia activation is not only a downstream consequence of microglia activation.

Chronic STING activation leads to the degeneration of dopaminergic neurons

We observed a reduced number of TH-positive neurons in the substantia nigra of STING ki mice, a reduced density of dopaminergic axon terminals and a reduced concentration of striatal dopamine (Figure 1G–I). These changes occurred in adult mice and were not present in juvenile mice (Figure 2G–I). The degeneration of dopaminergic neurons thus is a consequence of the prolonged inflammatory changes in our model.

On the Ifnar1^-/- and Casp1^-/- backgrounds, the density of dopaminergic axon terminals was already reduced (Figure 9B), making it difficult to assess the effect of N153S STING. Nonetheless, the relative reduction in TH fibre density in STING ki mice, as compared to STING WT mice, was smaller on the Ifnar1^-/- and Casp1^-/- backgrounds than in controls (Figure 9B), as was the extent of dopamine depletion (Figure 9C). These findings are consistent with the partial rescue of microglia activation in Ifnar1^-/- and Casp1^-/- mice (Figure 7D and E). They suggest that glia activation and secretion of inflammatory cytokines contribute to the degeneration of dopaminergic neurons – in line with previous findings demonstrating a role for inflammation in the pathogenesis of PD (Hall et al., 2018; Mollenhauer et al., 2019). In further studies, the developmental effects of Ifnar1 and Casp1 deficiency could be circumvented by using conditional knockout mice or pharmacological inhibitors. Oxidative stress was increased in STING ki mice (Figure 8) and cytoplasmic ROS were partially reduced in Casp1^-/- mice (Figure 8B), suggesting that oxidative stress might contribute to the N153S STING-induced degeneration of dopaminergic neurons. In addition, constant STING activity within dopaminergic neurons could contribute to their degeneration – both in our STING ki mice and in the pathogenesis of PD. Indeed, dopaminergic neurons accumulate oxidative damage as a consequence of dopamine synthesis and electrical pacemaking activity (Guzman et al., 2010), and even moderate oxidative stress can stimulate the STING pathway (Sliter et al., 2018; West et al., 2015).

Secreted immune mediators may trigger neuron loss upon STING activation (Murthy et al., 2020). For instance, TNFR1 is a member of the death receptor family, and can induce the recruitment of TNFR1-associated death domain protein (TRADD) and apoptosis upon Tnfa binding (Jayaraman et al., 2021; Murthy et al., 2020). Indeed, inhibition of TRADD can restore proteostasis and inhibits mutant tau-induced cell death (Xu et al., 2020). Next to Il1b cleavage, caspase-1 might also induce pyroptosis, an inflammatory form of cell death. After cleavage by caspase-1, gasdermin-D forms pores in the cell membrane (Shi et al., 2017). Rupture of the plasma membrane leads to the release of cytoplasmic content into the extracellular space, further fuelling inflammatory response (Voet et al., 2019). Furthermore, loss of ion gradient across the membrane makes neuronal functioning impossible. Besides increased oxidative stress or secreted immune mediators, neuronal STING activation may induce directly apoptosis. Emerging evidence suggests that STING activation induces endoplasmic reticulum (ER) stress and disrupt calcium homeostasis in various cell types (Cui et al., 2016; Petrasek et al., 2013; Wu et al., 2019), that, in turn, result in the loss of dopaminergic neurons (Gong et al., 2019). Further work with cell-type specific N153S STING expression will be required to determine the importance of STING activation within dopaminergic neurons for their degeneration in this model.

The degeneration of dopaminergic neurons observed in these mice was not severe. Based on findings with other mouse models of PD by ourselves and others (Bentea et al., 2015; Gong et al., 2019; Oliveras-Salvá et al., 2013), we do not expect a dopamine-dependent motor phenotype in these mice. Moreover, motor assessment is complicated by systemic inflammation in STING ki mice, affecting the lung and further organs (Luksch et al., 2019).

Accumulation of protein aggregates in STING ki mice

We observed an accumulation of phosphorylated and Triton X-100-insoluble aSyn, and an increased number of Thioflavin S positive cells in STING ki mice (Figure 3A–E). Collectively, these findings suggest that chronic STING activation induces aSyn pathology. They are consistent with the recent observation that priming rats with a mimic of viral dsDNA precipitates aSyn pathology (Olsen et al., 2019) and with the aSyn aggregation following viral encephalitis (Bantle et al., 2021). Inflammatory signals are therefore active promotors of aSyn pathology and not only responsive to aSyn pathology. Thioflavin S staining is, however, not specific for aSyn pathology, and STING-induced neuroinflammation could involve further proteins. Indeed, activation of NF-κB signalling in microglia was recently demonstrated to drive tau pathology (Wang et al., 2022).

The mechanism by which prolonged neuroinflammation leads to aSyn pathology is still unknown. Both inflammation and IFN induce the expression of the double-stranded (ds) RNA-dependent protein kinase (PKR) (Gal-Ben-Ari et al., 2018). PKR can phosphorylate aSyn at serine 129, resulting in aSyn pathology (Reimer et al., 2018). Moreover, clearance of aSyn aggregates occurs primarily through autophagy (Ebrahimi-Fakhari et al., 2011), and INFα increases expression of mammalian target of rapamycin (mTOR) (Liu et al., 2016), which is expected to reduce autophagy initiation. On the other hand, acute STING activation can induce autophagy (Hopfner and Hornung, 2020; Liu et al., 2018; Moretti et al., 2017). aSyn pathology in our model therefore could be explained by an exhaustion of the autophagy machinery, as it was suggested recently (Bido et al., 2021), and the overall effect of inflammatory pathways on autophagy and aSyn pathology could be bimodal. Accordingly, degeneration of dopaminergic neurons and accumulation of aSyn aggregates was also observed in mice deficient for IFNβ (Ejlerskov et al., 2015; Magalhaes et al., 2021).

Conclusions

This work provides evidence in a genetic model that chronic activation of STING signalling is sufficient for degeneration dopaminergic neurons. It has been demonstrated previously that blocking STING signalling or depleting STING is beneficial in animal models of ALS (Yu et al., 2020) and PD (Sliter et al., 2018). Yet, neuroinflammatory signalling involves many positive and negative feedback loops, so studies activating and blocking specific nodes are important to advance understanding and identify treatment targets. The interconnected nature and redundancy of neuroinflammation signalling was highlighted, for instance, by the strong inhibition of inflammasome signalling in Casp1^-/- mice, but the incomplete rescue of microglia activation and neurodegeneration.

This work is preliminary in many aspects. We have focused on dopaminergic neurons because we have been interested in pathways that cause their degeneration in the past, and STING has been linked to PD pathogenesis (Sliter et al., 2018). Yet, STING-induced neurodegeneration is expected to affect further neuron populations, which need to be assessed in future studies. Indeed, STING-induced neuroinflammation was not restricted to the substantia nigra, but also observed, for instance, in the cortex. Also, Thioflavin S accumulation likely involves other proteins than aSyn. STING-induced neurodegeneration and proteinopathies therefore need to be assessed more systematically in future studies, addressing the question whether some brain regions and neuron populations are more susceptible to STING-induced damage than others. Finally, genetic activation of STING in cell-types will be required to delineate the contributions of STING activation within microglia and neurons.

Materials and methods

Source of chemicals, antibodies, composition of buffers, equipment and software used in this study are listed in the Key Resources Table.

Animals

All animal experiments were carried out in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC) and approved by the Landesdirektion Dresden, Germany. Mice of both sexes were housed under a 12 hr light and dark cycle with free access to pelleted food and tap water in the Experimental Center, Technische Universität, Dresden, Germany. Heterozygous STING N153S/WT ki mice (STING ki) were previously described (Luksch et al., 2019). STING ki or STING WT mice were crossed to Ifnar1^-/- mice (a gift from Axel Roers, Dresden, Germany; Siedel et al., 2020) and Casp1^-/- mice (a gift from Stefan Winkler, Dresden, Germany ;Reinke et al., 2020).

For all genotypes, five-week-old (from here referred as juvenile) or 20–23 week-old (referred as adult) animals were sacrificed with an overdose of isoflurane (Baxter, Lessines, Belgium). For analyses of proteins, gene expression, catecholamine and oxidative stress, brains were rapidly removed from the skull and washed in ice-cold Tris-buffered saline (TBS, pH 7.4). Cortex and striatum were dissected, snap-frozen in liquid nitrogen and stored at –80 °C until use. For histology, mice were perfused transcardially with 4% paraformaldehyde (PFA) in TBS. After post-fixation (4% PFA, overnight) and cryoprotection (30% sucrose in TBS), 30 µm-thick coronal brain sections were cut in a cryostat (Leica, Germany).

Immunofluorescence stainings of mouse brain sections

Request a detailed protocol

To quantify the number of dopaminergic neurons in the substantia nigra (SN), every fifth section throughout the entire SN was stained for tyrosine hydroxylase (TH) as previously (Szegő et al., 2021). In brief, after blocking (2% bovine serum albumin, 0,3% Triton X-100 in TBS; 1 hr RT), sections were incubated with the primary antibody in blocking solution (two overnights), followed by the fluorescently labelled secondary antibody (Alexa 488 conjugated donkey anti-sheep, 1:2000, overnight). Sections were counterstained with Hoechst and mounted with Fluoromount-G.

To quantify the density of dopaminergic axon terminals (fibers) and neuroinflammation in the striatum, every sixth section throughout the entire striatum was stained with a cocktail of primary antibodies: TH (Pel Freeze, P40101, 1:1000), Iba1 (Wako, 019–19741, 1:1000) and GFAP (abcam, ab4674, 1:2000). As fluorescently labelled secondary antibodies, Alexa 488 conjugated donkey anti-sheep, Alexa 555 conjugated donkey anti-rabbit, Alexa 647 conjugated donkey anti-chicken were used (1:2000, overnight). Sections were counterstained with Hoechst and mounted with Fluoromount-G.

To detect cells containing inclusions of β-sheet containing proteins, mounted brain sections were stained with 0.1% Thioflavin-S in 70% ethanol 25 min, rinsed in 80% ethanol for 5 min and in distilled water for 5 min. After staining the nuclei with NucSpot nuclear stain, sections were mounted in Fluoromount-G (Szegő et al., 2019).

To quantify ASC-inflammasome assembly in glia cells, every tenth section throughout the entire striatum was stained with a cocktail of the following primary antibodies: ASC (Adipogen, 1:700, AG-25B-0006-C100), Iba1 (Synaptic Systems, 234004, 1:1000), and GFAP (abcam, ab4674, 1:2000). As fluorescently labelled secondary antibodies, Alexa 488 conjugated donkey anti-rabbit, Alexa 555 conjugated goat anti-guinea pig and Alexa 647 conjugated donkey anti-chicken were used (1:2000, overnight). Sections were counterstained with Hoechst and mounted with Fluoromount-G.

Quantification of dopaminergic neuron number, striatal fiber density and gliosis

Request a detailed protocol

The number of dopaminergic somata in the SN was determined by supervised manual counting by an experienced investigator blinded to the experimental groups. For each animal, every fifth section throughout the rostro-caudal extent of the SN (2.54 to –3.88 mm posterior to Bregma based on Paxinos and Franklin, 2001) was incorporated into the counting procedure. In each section, z stacks were acquired (step size: 2 µm, 5 slices in total) from both hemispheres with a 20 x objective (N.A 0.8, Axio Imager 2, Zeiss). Stacks were stitched to reconstruct the entire SN. After adjusting the threshold and carefully marking the borders of the SN, only TH-positive cell bodies with a visible nucleus in the blue channel were manually counted by ImageJ (1,53 c; Cell Counter plugin). All TH-positive neurons of each slices were counted. The total number of neurons for the entire SN of that hemisphere was estimated by multiplying the counted cell number by five, since every fifth section was used for this analysis.

For quantification of gliosis, five fluorescent images were acquired from every sixth striatal section stained for GFAP and Iba1 using a 20 x objective. After adjusting the threshold and noise removal (Background subtraction, rolling ball radius 50) from the individual images (separately for GFAP and Iba1 channels), the area fraction was determined by ImageJ from ten regions of interest per image. Results were analyzed using a generalized linear mixed model (glm) in RStudio with a hierarchically nested design (expressed as percent area) as previously (Szegő et al., 2021).

From the same striatal sections, the density of the dopaminergic axon terminals (fibers) was determined as described previously (Szego et al., 2012). In brief, z-stack images were acquired (five planes, 0.5 µm step size, 100 x objective, N.A. 1.4; Axio Imager 2, Zeiss). TH-positive fibers were delineated from the maximal intensity projection (ImageJ) after adjusting the threshold, noise removal and binarization, and density was expressed as percent area. Every sixth section per animal, five images per section and ten boxes per image were analyzed in a hierarchically nested design as above.

For quantification of the mean fluorescent intensity of the ASC signal, binary masks were first created (see above) separatly for microglia (Iba1 channel) and astroglia (GFAP channel). After removing background fluorescence (Background subtraction, rolling ball radius 50) from the individual ASC images, mean fluorescent intensity of the ASC signal was measured by ImageJ from all glia cells from a given microscope image. After adjusting the threshold of the ASC signal on the same individual images, area fraction of the ASC signal and the number of individual dots (ASC-specks) within microglia and within astroglia were also determined separately by ImageJ.

Protein analyses

Request a detailed protocol

To detect protein changes, cortical and striatal tissue were mechanically lysed in a buffer containing 250 mM sucrose, 50 mM TRIS (pH 7,5), 1 mM EDTA, 5 mM MgCl₂, 1% Triton X-100 in the presence of protease and phosphatase inhibitors (MedChem Express) as previously (Szego et al., 2012). Samples were centrifuged (14,000 g, 30 min, 4 °C) and protein concentration in the supernatant was determined with the BCA method (ThermoFisher, Germany). After boiling with 4 x Laemmli buffer (1 M Tris pH 6.8, 0.8% SDS, 40% glycerol, 5% β-mercaptoethanol, traces of bromophenol blue, 5 min, 95 °C), 5 µg protein was loaded onto a 4–20% Tris/glycine SDS gel for western blot analysis. Membranes were fixed in paraformaldehyde (10 min, RT) and blocked with 1% bovine serum albumin, 0,05% Tween 20 in TBS. Membranes were incubated first in the presence of antibodies against phosphorylated aSyn and aSyn, (Cell Signaling), then with βIII-tubulin as loading control (overnight, 4 °C). Following washing, membranes were incubated in the presence of horseradish peroxidase-conjugated secondary antibodies (donkey anti-mouse or donkey anti-rabbit). Signal was detected using chemiluminescent substrate and a camera-based system. ImageJ was used to determine the optical density of protein bands and all data were analyzed for each group (n = 5 animals/group) based on 3 independent blots. Optical densities were normalized to the expression of the density of the tubulin loading control of the same sample, and then expressed relative to the WT animals.

Triton X-100 solubility

Request a detailed protocol

For detection of aSyn in the Triton X-100 insoluble fraction, snap-frozen substantia nigra and striatal tissue were lysed in PBS containing 1% of Triton X-100, phosphatase inhibitors and protease inhibitors. Lysates were vortexed and incubated for 30 min at 4 °C. After centrifugation (14,000 g, 30 min, 4 °C), supernatant was used as Triton X-100 soluble fraction. The pellet was washed in ice-cold PBS, centrifuged again and re-dissolved with sonication (10 s) in 50 µl buffer containing 2% SDS, 75 mM Tris, 15% glycerin, 3.75 mM EDTA pH 7.4 and protease inhibitors. Solution was briefly centrifuged (5 min, 14 000 g, RT), and it was used as Triton X-100 insoluble fraction. 10 µg of Triton X-100 soluble lysate or 10 µl Triton X-100 insoluble fraction were loaded onto a 4–20% Tris/glycine SDS gel for western blot analysis, and processed as above to detect signals of aSyn and βIII-tubulin. To obtain the ratio of aSyn within the Triton X-100 soluble and insoluble fractions, data was normalized (1) to the tubulin loading control within line, then (2) to the soluble aSyn/tubulin ration, and finally (3) to the values of STING WT animals.

Biochemical assays

Request a detailed protocol

Cytoplasmic reactive oxygen species (ROS) production and mitochondrial ROS production, total nitrite levels were measured as described previously (Pais et al., 2013; Szegő et al., 2019). In brief, striatal tissue were lysed in ice-cold in PBS and centrifuged (14,000 g, 30 min, 4 °C). Cytoplasmic ROS was measured using dichlorodihydroﬂuorescein diacetate (DCFH-DA; 10 mM, 37 C, 30 min), mitochondrial ROS was measured using MitoSOX (200 nM, 20 min, 37 C). Fluorescence at 485/530 nm (DCFH-DA) or 510/580 nm (MitoSox) was measured with plate reader. The production of NO by iNOS was measured indirectly by assaying nitrites in the lysate using the Griess reaction (Pais et al., 2013). In brief, 10 µg of lysates were incubated with equal amount of Griess reagent (1% sulphanilamide, 0.1% naphthylethylenediamine in 2% phosphoric acid solution) for 20 min at room temperature. Absorbance was read at 550 nm.

Gene expression analyses

Request a detailed protocol

Total RNA was extracted from snap frozen dissected prefrontal cortex tissue by using the RNeasy Mini Kit (Qiagen, Germany) according to the manufacturer’s instructions. cDNA was generated by MMLV reverse transcription (Promega Germany). Quantitative Real Time PCR assays were carried out by using QuantStudio 5 (Thermo Fisher Scientific, Germany) and GoTaqaPCR Master Mix with SYBR green fluorescence (Promega, Germany). PCR primer sequences were retrieved from the Primer Bank database (Spandidos et al., 2010). Expression of genes was normalized to the expression of the housekeeping genes (Hprt1, Rpl13a, Eef2) and to the STING WT by using the ΔΔCt method. Sequences of primers are listed in the Key Resources Table.

Legend Plex

Request a detailed protocol

LEGENDplex is a multiplex bead-based assay using the basic methodology of ELISA assay. Briefly, snap-frozen dissected STR tissue was homogenized in PBS add 0.5 % NP-40 and protease inhibitor cocktail (Sigma-Aldrich, Germany). The clarified supernatant after centrifugation was used for cytokine determination by Mouse cytokine release syndrome panel (Biolegend) according manufactures introductions. Quantity of cytokines was calculated per mg protein in each lysate.

Statistical analyses

Request a detailed protocol

In graphs, markers represent individual animals; lines represent mean and standard deviation (SD) of all animals. Data normality was tested by the Kolmogorov-Smirnov test and graphically by QQ plot (R, version 2.8.0; R Development Core Team, 2020). Grubbs test was used to identify outliers. t-test, Mann-Whitney test or two-way ANOVA were performed using GraphPad Prism (Versions 5.01 and 9.0.0). Linear regression and principal component analysis was performed using R (version 4.2.1.). For generalized linear mixed-effects model (Szegő et al., 2021), animal, section and image were used as random effects nested within each other (R package: lme4). p values are indicated in the graphs by symbols with * representing p<0.05, ** representing p<0.01, *** representing p<0.001. Exact p values are given in the Figure legends.

The number of replicates used for the study was determined by prior experience and did not result from a formal sample size estimation. The ‘n’ indicated for each figure in the figure legend represents the number of animals (biological replicates).

Appendix 1

Appendix 1—key resources table

Reagent type (species) or resource	Designation	Source or reference	Identifiers	Additional information
Strain (Mus musculus)	STING ki (STING N153S knock-in mice)	Luksch et al., 2019		C57BL/6 N background, not the same mouse line as Warner et al., 2017
Strain (Mus musculus)	Ifnar1^-/-	Siedel et al., 2020		backcrossed 20 times to C57BL/6
Strain (Mus musculus)	Casp1^-/-	Reinke et al., 2020		C57BL/6 background
Antibody	Anti-Iba1, rabbit polyclonal	Fujifilm Wako Chemicals	Cat# 019–19741	1:1000
Antibody	Anti-GFAP, chicken polyclonal	Abcam	Cat# ab4674	1:2000
Antibody	Anti- NFκB p65 (D14E12), rabbit polyclonal	Cell Signaling Technology	Cat# 8242	1:500
Antibody	Anti- Tubulin βIII, rabbit polyclonal	Covance	Cat# PRB-435P	1:5000
Antibody	Anti-phospho-a-synuclein, rabbit monoclonal	Abcam	Cat# ab51253	1:1000
Antibody	Anti-a-synuclein, mouse monoclonal	BD Bioscience	Cat# 610787	1:2000
Antibody	Anti- TH, sheep, polyclonal	Pel-Freeze	Cat# P40101	1:2000
Antibody	Anti-synapsin, chicken monoclonal	Synaptic Systems	Cat# 160002	1:1000
Antibody	Anti-homer, rabbit monoclonal	Synaptic Systems	Cat# 106006	1:1000
Antibody	Anti-ASC, rabbit monoclonal	Adipogen	Cat# AG-25B-0006-C100	1:700
Antibody	Anti-IL1b, rabbit monoclonal	Cell Signaling Technology	Cat# 2022	1:300
Antibody	Anti- NLRP3, mouse monoclonal	Adipogen	Cat# AG-20B-00060006	1:1000
Antibody	Anti- NeuN, chicken polyclonal	Synaptic Systems	Cat# 266006	1:1500
Antibody	Anti- HDAC1, mouse, monoclonal	Thermo Fisher	Cat# MA5-1807	1:1000
Antibody	Anti- IRF3, rabbit polyclonal	Santa Cruz	Cat# sc-9082	1:1000
Antibody	Anti- GAPDH, mouse, monoclonal	Millipore	Cat# MAB374	1:5000
Antibody	HRP conjugated donkey anti-mouse polyclonal	Jackson ImmunoResearch	Cat# 715-035-150	1:5000
Antibody	HRP conjugated donkey anti-rabbit polyclonal	Jackson ImmunoResearch	Cat# 711-035-152	1:5000
Antibody	Alexa 555 conjugated donkey anti-rabbit polyclonal	Invitrogen	Cat# A31572	1:2000
Antibody	Alexa 647 conjugated donkey anti-chicken polyclonal	Jackson ImmunoResearch	Cat# 703-605-155	1:2000
Antibody	Alexa 488 conjugated donkey anti-sheep polyclonal	Invitrogen	Cat# A11015	1:2000
Antibody	Alexa 488 conjugated donkey anti-rabbit polyclonal	Invitrogen	Cat# A21206	1:2000
Sequence-based reagent	Ifi44 fw primer	This paper	PCR primer	AACTGACTGCTC GCAATAATGT
Sequence-based reagent	Ifi44 rev primer	This paper	PCR primer	GTAACACAGCA ATGCCTCTTGT
Sequence-based reagent	Mx1 fw primer	This paper	PCR primer	AACCCTGCTACCTTTCAA
Sequence-based reagent	Mx1 rev primer	This paper	PCR primer	AAGCATCGTTT TCTCTATTTC
Sequence-based reagent	Sting1 fw primer	This paper	PCR primer	CTGCTGACATAT ACCTCAGTTG
Sequence-based reagent	Sting1 rev primer	This paper	PCR primer	GAGCATGTTGT TATGTAGCTG
Sequence-based reagent	Cxcl10 fw primer	This paper	PCR primer	CCAAGTGCTGC CGTCATTTTC
Sequence-based reagent	Cxcl10 rev primer	This paper	PCR primer	GGCTCGCAGG GATGATTTCAA
Sequence-based reagent	Tnfa fw primer	This paper	PCR primer	CCTGTAGCCC ACGTCGTAG
Sequence-based reagent	Tnfa rev primer	This paper	PCR primer	GGGAGTAGACA AGGTACAACCC
Sequence-based reagent	Casp1 fw primer	This paper	PCR primer	GCTGCCTGCCC AGAGCACAAG
Sequence-based reagent	Casp1 rev primer	This paper	PCR primer	CTCTTCAGAGTCTCTTACTG
Sequence-based reagent	Il1b fw primer	This paper	PCR primer	GAAATGCCACC TTTTGACAGTG
Sequence-based reagent	Il1b rev primer	This paper	PCR primer	TGGATGCTCTCA TCAGGACAG
Sequence-based reagent	Hprt1 fw primer	This paper	PCR primer	TCAGTCAACGGG GGACATAAA
Sequence-based reagent	Hprt1 rev primer	This paper	PCR primer	GGGGCTGTACT GCTTAACCAG
Sequence-based reagent	Rpl13 fw primer	This paper	PCR primer	AGCCTACCAGAA AGTTTGCTTAC
Sequence-based reagent	Rpl13 rev primer	This paper	PCR primer	GCTTCTTCTTCC GATAGTGCATC
Sequence-based reagent	Eef2 fw primer	This paper	PCR primer	CCGACTCCC TTGTGTGCAA
Sequence-based reagent	Eef2 rev primer	This paper	PCR primer	AGTTCAGGTCG TTCTCAGAGAG
Sequence-based reagent	Ym1 fw primer	This paper	PCR primer	CATTCAGTCAG TTATCAGATTCC
Sequence-based reagent	Ym1 rev primer	This paper	PCR primer	AGTGAGTAGCAGCCTTGG
Sequence-based reagent	Il4 fw primer	This paper	PCR primer	AGATGGATGTGCC AAACGTCCTCA
Sequence-based reagent	Il4 rev primer	This paper	PCR primer	AATATGCGAAGCA CCTTGGAAGCC
Sequence-based reagent	Nos2 fw primer	This paper	PCR primer	CTGCTGGTGGTGAC AAGCACATTT
Sequence-based reagent	Nos2 rev primer	This paper	PCR primer	ATGTCATGAGCAAA GGCGCAGAAC
Sequence-based reagent	Retnl1 fw primer	This paper	PCR primer	TGGAGAATAAGGTCAAGGAAC
Sequence-based reagent	Retnlb rev primer	This paper	PCR primer	GTCAACGAGTAAGCACAGG
Commercial assay or kit	Pierce Micro BCA Protein-Assay-Kit	Thermo Fisher Scientific Inc	Cat# 23235
Commercial assay or kit	WesternBright Chemilumineszenz Substrat Sirius	Biozym Scientific GmbH	Cat# 541019
Commercial assay or kit	M-MLV Reverse Transriptase Kit	Promega	Cat# M1701
Commercial assay or kit	SV Total RNA Isolation System	Promega	Cat# Z3101
Commercial assay or kit	GoTaq qPCR Master Mix	Promega	Cat# A6002
Chemical compound, drug	PhosSTOP phosphatase inhibitor	Sigma-Aldrich	Cat# 4906845001
Chemical compound, drug	Precision Plus Protein WesternC Protein Standards	BioRad	Cat# 1610376
Chemical compound, drug	RNasin Ribonuclease Inhibitor	Promega	Cat# N2511
Chemical compound, drug	Deoxynucleotide Triphosphates (dNTPs)	Promega	Cat# U1205
Chemical compound, drug	M-MLV 5 x Reaction Buffer	Promega	Cat# M1701
Chemical compound, drug	Fluoromount-G	Southern Biotech	Cat# 0100–01
Chemical compound, drug	NucSpot Live 650 Nuclear Stain	Biotium	Cat# 40082
Chemical compound, drug	Thioflavin S	Sigma-Aldrich	Cat# T1892
Chemical compound, drug	Mitosox	Thermo Fisher	Cat# M36008
Chemical compound, drug	Di(Acetoxymethyl Ester) (6-Carboxy-2',7'- Dichlorodihydrofluorescein Diacetate) (DCFH-DA)	Thermo Fisher	Cat# C2938
Software, algorithm	GraphPad Prism 5. 01 and 9.0.0	GraphPad Software
Software, algorithm	ImageJ Fiji	Wayne Rasband (NIH)
Software, algorithm	QuantStudio5 qPCR Data Analysis Software	Thermo Fisher Scientific Inc
Other	QuantStudio 5 Real-Time PCR System	Thermo Fisher Scientific Inc
Other	Zeiss Axio Observer Z1	Carl Zeiss
Other	Zeiss Spinning Disc	Carl Zeiss
Other	Infinite 200 M Multimode- Plate-Reader	Tecan Group

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file.

References

1. Anderson JP
2. Walker DE
3. Goldstein JM
4. de Laat R
5. Banducci K
6. Caccavello RJ
7. Barbour R
8. Huang J
9. Kling K
10. Lee M
11. Diep L
12. Keim PS
13. Shen X
14. Chataway T
15. Schlossmacher MG
16. Seubert P
17. Schenk D
18. Sinha S
19. Gai WP
20. Chilcote TJ
(2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease
The Journal of Biological Chemistry 281:29739–29752.
https://doi.org/10.1074/jbc.M600933200
- PubMed
- Google Scholar
1. Balka KR
2. Louis C
3. Saunders TL
4. Smith AM
5. Calleja DJ
6. D’Silva DB
7. Moghaddas F
8. Tailler M
9. Lawlor KE
10. Zhan Y
11. Burns CJ
12. Wicks IP
13. Miner JJ
14. Kile BT
15. Masters SL
16. De Nardo D
(2020) Tbk1 and IKKε act redundantly to mediate STING-induced NF-κB responses in myeloid cells
Cell Reports 31:107492.
https://doi.org/10.1016/j.celrep.2020.03.056
- PubMed
- Google Scholar
1. Balka K.R
2. De Nardo D
(2021) Molecular and spatial mechanisms governing sting signalling
The FEBS Journal 288:5504–5529.
https://doi.org/10.1111/febs.15640
- PubMed
- Google Scholar
1. Bantle CM
2. Rocha SM
3. French CT
4. Phillips AT
5. Tran K
6. Olson KE
7. Bass TA
8. Aboellail T
9. Smeyne RJ
10. Tjalkens RB
(2021) Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis
Experimental Neurology 346:113845.
https://doi.org/10.1016/j.expneurol.2021.113845
- PubMed
- Google Scholar
1. Bauernfeind FG
2. Horvath G
3. Stutz A
4. Alnemri ES
5. MacDonald K
6. Speert D
7. Fernandes-Alnemri T
8. Wu J
9. Monks BG
10. Fitzgerald KA
11. Hornung V
12. Latz E
(2009) Cutting edge: NF-kappab activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression
Journal of Immunology 183:787–791.
https://doi.org/10.4049/jimmunol.0901363
- PubMed
- Google Scholar
(2015) Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of ser129 phosphorylated α-synuclein
Frontiers in Behavioral Neuroscience 9:68.
https://doi.org/10.3389/fnbeh.2015.00068
- PubMed
- Google Scholar
1. Bido S
2. Muggeo S
3. Massimino L
4. Marzi MJ
5. Giannelli SG
6. Melacini E
7. Nannoni M
8. Gambarè D
9. Bellini E
10. Ordazzo G
11. Rossi G
12. Maffezzini C
13. Iannelli A
14. Luoni M
15. Bagicaluppi M
16. Gregori S
17. Nicassio F
18. Broccoli V
(2021) Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity
Nat Commun 121:1–15.
https://doi.org/10.1038/s41467-021-26519-x
- Google Scholar
1. Broz P
2. Dixit VM
(2016) Inflammasomes: mechanism of assembly, regulation and signalling
Nat Rev Immunol 16:407–420.
https://doi.org/10.1038/nri.2016.58
- Google Scholar
1. Chatterjee K
2. Roy A
3. Banerjee R
4. Choudhury S
5. Mondal B
6. Halder S
7. Basu P
8. Shubham S
9. Dey S
10. Kumar H
(2020) Inflammasome and α-synuclein in parkinson’s disease: A cross-sectional study
Journal of Neuroimmunology 338:577089.
https://doi.org/10.1016/j.jneuroim.2019.577089
- PubMed
- Google Scholar
1. Chen Q
2. Sun L
3. Chen ZJ
(2016) Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing
Nature Immunology 17:1142–1149.
https://doi.org/10.1038/ni.3558
- PubMed
- Google Scholar
1. Chen K
2. Lai C
3. Su Y
4. Bao WD
5. Yang LN
6. Xu PP
7. Zhu LQ
(2021) CGAS-STING-mediated IFN-I response in host defense and neuro-inflammatory diseases
Curr Neuropharmacol 19:362–371.
https://doi.org/10.2174/1570159X19666210924110144
- Google Scholar
(1990) Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B
Molecular and Cellular Biology 10:1498–1506.
https://doi.org/10.1128/mcb.10.4.1498-1506.1990
- PubMed
- Google Scholar
1. Crow YJ
2. Casanova JL
(2014) STING-associated vasculopathy with onset in infancy -- a new interferonopathy
The New England Journal of Medicine 371:568–571.
https://doi.org/10.1056/NEJMe1407246
- PubMed
- Google Scholar
1. Cui Y
2. Zhao D
3. Sreevatsan S
4. Liu C
5. Yang W
6. Song Z
7. Yang L
8. Barrow P
9. Zhou X
(2016) Mycobacterium bovis induces endoplasmic reticulum stress mediated-apoptosis by activating IRF3 in a murine macrophage cell line
Frontiers in Cellular and Infection Microbiology 6:182.
https://doi.org/10.3389/fcimb.2016.00182
- PubMed
- Google Scholar
(2021) The cGAS-STING pathway as a therapeutic target in inflammatory diseases
Nature Reviews. Immunology 21:548–569.
https://doi.org/10.1038/s41577-021-00524-z
- PubMed
- Google Scholar
(2011) Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein
The Journal of Neuroscience 31:14508–14520.
https://doi.org/10.1523/JNEUROSCI.1560-11.2011
- PubMed
- Google Scholar
1. Ejlerskov P
2. Hultberg JG
3. Wang JY
4. Carlsson R
5. Ambjørn M
6. Kuss M
7. Liu Y
8. Porcu G
9. Kolkova K
10. Friis Rundsten C
11. Ruscher K
12. Pakkenberg B
13. Goldmann T
14. Loreth D
15. Prinz M
16. Rubinsztein DC
17. Issazadeh-Navikas S
(2015) Lack of neuronal IFN-β-IFNAR causes Lewy body- and Parkinson’s disease-like dementia
Cell 163:324–339.
https://doi.org/10.1016/j.cell.2015.08.069
- PubMed
- Google Scholar
(2001) Dendrodendritic inhibition through reversal of dopamine transport
Science 293:2465–2470.
https://doi.org/10.1126/science.1060645
- PubMed
- Google Scholar
1. Freischmidt A
2. Wieland T
3. Richter B
4. Ruf W
5. Schaeffer V
6. Müller K
7. Marroquin N
8. Nordin F
9. Hübers A
10. Weydt P
11. Pinto S
12. Press R
13. Millecamps S
14. Molko N
15. Bernard E
16. Desnuelle C
17. Soriani M-H
18. Dorst J
19. Graf E
20. Nordström U
21. Feiler MS
22. Putz S
23. Boeckers TM
24. Meyer T
25. Winkler AS
26. Winkelman J
27. de Carvalho M
28. Thal DR
29. Otto M
30. Brännström T
31. Volk AE
32. Kursula P
33. Danzer KM
34. Lichtner P
35. Dikic I
36. Meitinger T
37. Ludolph AC
38. Strom TM
39. Andersen PM
40. Weishaupt JH
(2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Nature Neuroscience 18:631–636.
https://doi.org/10.1038/nn.4000
- PubMed
- Google Scholar
1. Frémond ML
2. Hadchouel A
3. Berteloot L
4. Melki I
5. Bresson V
6. Barnabei L
7. Jeremiah N
8. Belot A
9. Bondet V
10. Brocq O
11. Chan D
12. Dagher R
13. Dubus JC
14. Duffy D
15. Feuillet-Soummer S
16. Fusaro M
17. Gattorno M
18. Insalaco A
19. Jeziorski E
20. Kitabayashi N
21. Lopez-Corbeto M
22. Mazingue F
23. Morren MA
24. Rice GI
25. Rivière JG
26. Seabra L
27. Sirvente J
28. Soler-Palacin P
29. Stremler-Le Bel N
30. Thouvenin G
31. Thumerelle C
32. Van Aerde E
33. Volpi S
34. Willcocks S
35. Wouters C
36. Breton S
37. Molina T
38. Bader-Meunier B
39. Moshous D
40. Fischer A
41. Blanche S
42. Rieux-Laucat F
43. Crow YJ
44. Neven B
(2021) Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients
The Journal of Allergy and Clinical Immunology. In Practice 9:803–818.
https://doi.org/10.1016/j.jaip.2020.11.007
- PubMed
- Google Scholar
1. Froula JM
2. Castellana-Cruz M
3. Anabtawi NM
4. Camino JD
5. Chen SW
6. Thrasher DR
7. Freire J
8. Yazdi AA
9. Fleming S
10. Dobson CM
11. Kumita JR
12. Cremades N
13. Volpicelli-Daley LA
(2019) Defining α-synuclein species responsible for Parkinson’s disease phenotypes in mice
The Journal of Biological Chemistry 294:10392–10406.
https://doi.org/10.1074/jbc.RA119.007743
- PubMed
- Google Scholar
1. Fujiwara H
2. Hasegawa M
3. Dohmae N
4. Kawashima A
5. Masliah E
6. Goldberg MS
7. Shen J
8. Takio K
9. Iwatsubo T
(2002) Alpha-Synuclein is phosphorylated in synucleinopathy lesions
Nature Cell Biology 4:160–164.
https://doi.org/10.1038/ncb748
- PubMed
- Google Scholar
1. Gaidt MM
2. Ebert TS
3. Chauhan D
4. Ramshorn K
5. Pinci F
6. Zuber S
7. O’Duill F
8. Schmid-Burgk JL
9. Hoss F
10. Buhmann R
11. Wittmann G
12. Latz E
13. Subklewe M
14. Hornung V
(2017) The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3
Cell 171:1110–1124.
https://doi.org/10.1016/j.cell.2017.09.039
- PubMed
- Google Scholar
(2018) Pkr: a kinase to remember
Frontiers in Molecular Neuroscience 11:480.
https://doi.org/10.3389/fnmol.2018.00480
- PubMed
- Google Scholar
1. Gong J
2. Szego ÉM
3. Leonov A
4. Benito E
5. Becker S
6. Fischer A
7. Zweckstetter M
8. Outeiro T
9. Schneider A
(2019) Translocator protein ligand protects against neurodegeneration in the MPTP mouse model of parkinsonism
The Journal of Neuroscience 39:3752–3769.
https://doi.org/10.1523/JNEUROSCI.2070-18.2019
- PubMed
- Google Scholar
(2010) Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Nature 468:696–700.
https://doi.org/10.1038/nature09536
- PubMed
- Google Scholar
1. Hall S
2. Janelidze S
3. Surova Y
4. Widner H
5. Zetterberg H
6. Hansson O
(2018) Cerebrospinal fluid concentrations of inflammatory markers in parkinson’s disease and atypical parkinsonian disorders
Scientific Reports 8:13276.
https://doi.org/10.1038/s41598-018-31517-z
- PubMed
- Google Scholar
(2021) Inflammation in experimental models of α-synucleinopathies
Movement Disorders 36:37–49.
https://doi.org/10.1002/mds.28264
- PubMed
- Google Scholar
(2018) Inflammasome signalling in brain function and neurodegenerative disease
Nature Reviews. Neuroscience 19:610–621.
https://doi.org/10.1038/s41583-018-0055-7
- PubMed
- Google Scholar
1. Hinkle JT
2. Patel J
3. Panicker N
4. Karuppagounder SS
5. Biswas D
6. Belingon B
7. Chen R
8. Brahmachari S
9. Pletnikova O
10. Troncoso JC
11. Dawson VL
12. Dawson TM
(2022) Sting mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
PNAS 119:e2118819119.
https://doi.org/10.1073/pnas.2118819119
- PubMed
- Google Scholar
1. Hirsch EC
2. Standaert DG
(2021) Ten unsolved questions about neuroinflammation in Parkinson’s disease
Movement Disorders 36:16–24.
https://doi.org/10.1002/mds.28075
- PubMed
- Google Scholar
1. Hiscott J
2. Marois J
3. Garoufalis J
4. D’Addario M
5. Roulston A
6. Kwan I
7. Pepin N
8. Lacoste J
9. Nguyen H
10. Bensi G
(1993) Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop
Molecular and Cellular Biology 13:6231–6240.
https://doi.org/10.1128/mcb.13.10.6231-6240.1993
- PubMed
- Google Scholar
1. Hopfner KP
2. Hornung V
(2020) Molecular mechanisms and cellular functions of cGAS-STING signalling
Nature Reviews. Molecular Cell Biology 21:501–521.
https://doi.org/10.1038/s41580-020-0244-x
- PubMed
- Google Scholar
1. Jayaraman A
2. Htike TT
3. James R
4. Picon C
5. Reynolds R
(2021) Tnf-mediated neuroinflammation is linked to neuronal necroptosis in alzheimer’s disease hippocampus
Acta Neuropathologica Communications 9:159.
https://doi.org/10.1186/s40478-021-01264-w
- PubMed
- Google Scholar
1. Jeffries AM
2. Marriott I
(2017) Human microglia and astrocytes express cGAS-STING viral sensing components
Neuroscience Letters 658:53–56.
https://doi.org/10.1016/j.neulet.2017.08.039
- PubMed
- Google Scholar
1. Keren-Shaul H
2. Spinrad A
3. Weiner A
4. Matcovitch-Natan O
5. Dvir-Szternfeld R
6. Ulland TK
7. David E
8. Baruch K
9. Lara-Astaiso D
10. Toth B
11. Itzkovitz S
12. Colonna M
13. Schwartz M
14. Amit I
(2017) A unique microglia type associated with restricting development of Alzheimer’s disease
Cell 169:1276–1290.
https://doi.org/10.1016/j.cell.2017.05.018
- PubMed
- Google Scholar
1. Komnig D
2. Dagli TC
3. Habib P
4. Zeyen T
5. Schulz JB
6. Falkenburger BH
(2018) Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson’s disease and does not lead to a sustainable increase of brain-derived neurotrophic factor
Journal of Neurochemistry 147:678–691.
https://doi.org/10.1111/jnc.14575
- PubMed
- Google Scholar
(2019) Regulatory effects and interactions of the Wnt and OPG-RANKL-RANK signaling at the bone-cartilage interface in osteoarthritis
International Journal of Molecular Sciences 20:E4653.
https://doi.org/10.3390/ijms20184653
- PubMed
- Google Scholar
1. Kwon HS
2. Koh SH
(2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Translational Neurodegeneration 9:42.
https://doi.org/10.1186/s40035-020-00221-2
- PubMed
- Google Scholar
1. Li T
2. Chen ZJ
(2018) The cgas-cgamp-sting pathway connects DNA damage to inflammation, senescence, and cancer
The Journal of Experimental Medicine 215:1287–1299.
https://doi.org/10.1084/jem.20180139
- PubMed
- Google Scholar
1. Ling ZD
2. Potter ED
3. Lipton JW
4. Carvey PM
(1998) Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines
Experimental Neurology 149:411–423.
https://doi.org/10.1006/exnr.1998.6715
- PubMed
- Google Scholar
1. Liu Y
2. Jesus AA
3. Marrero B
4. Yang D
5. Ramsey SE
6. Sanchez GAM
7. Tenbrock K
8. Wittkowski H
9. Jones OY
10. Kuehn HS
11. Lee C-CR
12. DiMattia MA
13. Cowen EW
14. Gonzalez B
15. Palmer I
16. DiGiovanna JJ
17. Biancotto A
18. Kim H
19. Tsai WL
20. Trier AM
21. Huang Y
22. Stone DL
23. Hill S
24. Kim HJ
25. St Hilaire C
26. Gurprasad S
27. Plass N
28. Chapelle D
29. Horkayne-Szakaly I
30. Foell D
31. Barysenka A
32. Candotti F
33. Holland SM
34. Hughes JD
35. Mehmet H
36. Issekutz AC
37. Raffeld M
38. McElwee J
39. Fontana JR
40. Minniti CP
41. Moir S
42. Kastner DL
43. Gadina M
44. Steven AC
45. Wingfield PT
46. Brooks SR
47. Rosenzweig SD
48. Fleisher TA
49. Deng Z
50. Boehm M
51. Paller AS
52. Goldbach-Mansky R
(2014) Activated sting in a vascular and pulmonary syndrome
The New England Journal of Medicine 371:507–518.
https://doi.org/10.1056/NEJMoa1312625
- PubMed
- Google Scholar
1. Liu WL
2. Yang HC
3. Hsu CS
4. Wang CC
5. Wang TS
6. Kao JH
7. Chen DS
(2016) Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mtor pathway
PNAS 113:14799–14804.
https://doi.org/10.1073/pnas.1618517114
- PubMed
- Google Scholar
(2018) Inflammation-Induced, STING-dependent autophagy restricts Zika virus infection in the Drosophila brain
Cell Host & Microbe 24:57–68.
https://doi.org/10.1016/j.chom.2018.05.022
- PubMed
- Google Scholar
1. Luksch H
2. Stinson WA
3. Platt DJ
4. Qian W
5. Kalugotla G
6. Miner CA
7. Bennion BG
8. Gerbaulet A
9. Rösen-Wolff A
10. Miner JJ
(2019) STING-associated lung disease in mice relies on T cells but not type I interferon
The Journal of Allergy and Clinical Immunology 144:254–266.
https://doi.org/10.1016/j.jaci.2019.01.044
- PubMed
- Google Scholar
1. Magalhaes J
2. Tresse E
3. Ejlerskov P
4. Hu E
5. Liu Y
6. Marin A
7. Montalant A
8. Satriano L
9. Rundsten CF
10. Carlsen EMM
11. Rydbirk R
12. Sharifi-Zarchi A
13. Andersen JB
14. Aznar S
15. Brudek T
16. Khodosevich K
17. Prinz M
18. Perrier JFM
19. Sharma M
20. Gasser T
21. Issazadeh-Navikas S
(2021) PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia
Molecular Psychiatry 26:6083–6099.
https://doi.org/10.1038/s41380-021-01207-w
- PubMed
- Google Scholar
(2019) Baseline predictors for progression 4 years after Parkinson’s disease diagnosis in the de novo Parkinson cohort (denopa)
Movement Disorders 34:67–77.
https://doi.org/10.1002/mds.27492
- PubMed
- Google Scholar
1. Moretti J
2. Roy S
3. Bozec D
4. Martinez J
5. Chapman JR
6. Ueberheide B
7. Lamming DW
8. Chen ZJ
9. Horng T
10. Yeretssian G
11. Green DR
12. Blander JM
(2017) Sting senses microbial viability to orchestrate stress-mediated autophagy of the endoplasmic reticulum
Cell 171:809–823.
https://doi.org/10.1016/j.cell.2017.09.034
- PubMed
- Google Scholar
(2019) Dna sensing by the cGAS-STING pathway in health and disease
Nature Reviews. Genetics 20:657–674.
https://doi.org/10.1038/s41576-019-0151-1
- PubMed
- Google Scholar
(2020) Crosstalk between cGAS-STING signaling and cell death
Cell Death and Differentiation 27:2989–3003.
https://doi.org/10.1038/s41418-020-00624-8
- PubMed
- Google Scholar
1. Neumann M
2. Kahle PJ
3. Giasson BI
4. Ozmen L
5. Borroni E
6. Spooren W
7. Müller V
8. Odoy S
9. Fujiwara H
10. Hasegawa M
11. Iwatsubo T
12. Trojanowski JQ
13. Kretzschmar HA
14. Haass C
(2002) Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies
The Journal of Clinical Investigation 110:1429–1439.
https://doi.org/10.1172/JCI15777
- PubMed
- Google Scholar
1. Noguchi S
2. Yamada N
3. Kumazaki M
4. Yasui Y
5. Iwasaki J
6. Naito S
7. Akao Y
(2013) Socs7, a target gene of microrna-145, regulates interferon-β induction through STAT3 nuclear translocation in bladder cancer cells
Cell Death Dis 4:e482.
https://doi.org/10.1038/CDDIS.2013.11
- Google Scholar
(2013) RAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration
Mol Neurodegener 8:44.
https://doi.org/10.1186/1750-1326-8-44
- Google Scholar
1. Olsen LK
2. Cairns AG
3. Ådén J
4. Moriarty N
5. Cabre S
6. Alamilla VR
7. Almqvist F
8. Dowd E
9. McKernan DP
(2019) Viral mimetic priming enhances α-synuclein-induced degeneration: implications for parkinson’s disease
Brain, Behavior, and Immunity 80:525–535.
https://doi.org/10.1016/j.bbi.2019.04.036
- PubMed
- Google Scholar
(2016) Microglial M1/M2 polarization and metabolic states
British Journal of Pharmacology 173:649–665.
https://doi.org/10.1111/bph.13139
- PubMed
- Google Scholar
(2013) The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation
The EMBO Journal 32:2603–2616.
https://doi.org/10.1038/emboj.2013.200
- PubMed
- Google Scholar
(2021) Signaling by cgas-sting in neurodegeneration, neuroinflammation, and aging
Trends in Neurosciences 44:83–96.
https://doi.org/10.1016/j.tins.2020.10.008
- PubMed
- Google Scholar
Book
1. Paxinos G
2. Franklin KBJ.
(2001)
Paxinos and Franklin’s the Mouse Brain in Stereotaxic Coordinates

Academic Press.
- Google Scholar
(2013) STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease
PNAS 110:16544–16549.
https://doi.org/10.1073/pnas.1308331110
- PubMed
- Google Scholar
Software
1. R Development Core Team
(2020) R: A language and environment for statistical computing
R Foundation for Statistical Computing, Vienna, Austria.

https://www.R-project.org/
1. Reimer L
2. Vesterager LB
3. Betzer C
4. Zheng J
5. Nielsen LD
6. Kofoed RH
7. Lassen LB
8. Bølcho U
9. Paludan SR
10. Fog K
11. Jensen PH
(2018) Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death
Neurobiology of Disease 115:17–28.
https://doi.org/10.1016/j.nbd.2018.03.001
- PubMed
- Google Scholar
1. Reinke S
2. Linge M
3. Diebner HH
4. Luksch H
5. Glage S
6. Gocht A
7. Robertson AAB
8. Cooper MA
9. Hofmann SR
10. Naumann R
11. Sarov M
12. Behrendt R
13. Roers A
14. Pessler F
15. Roesler J
16. Rösen-Wolff A
17. Winkler S
(2020) Non-Canonical caspase-1 signaling drives RIP2-dependent and TNF-α-mediated inflammation in vivo
Cell Reports 30:2501–2511.
https://doi.org/10.1016/j.celrep.2020.01.090
- PubMed
- Google Scholar
(2005) Angiotensin II and interleukin-1 interact to increase generation of dopaminergic neurons from neurospheres of mesencephalic precursors
Brain Research. Developmental Brain Research 158:120–122.
https://doi.org/10.1016/j.devbrainres.2005.06.009
- PubMed
- Google Scholar
1. Samuel F
2. Flavin WP
3. Iqbal S
4. Pacelli C
5. Sri Renganathan SD
6. Trudeau L-E
7. Campbell EM
8. Fraser PE
9. Tandon A
(2016) Effects of serine 129 phosphorylation on α-synuclein aggregation, membrane association, and internalization
The Journal of Biological Chemistry 291:4374–4385.
https://doi.org/10.1074/jbc.M115.705095
- PubMed
- Google Scholar
1. Schroder K
2. Tschopp J
(2010) The inflammasomes
Cell 140:821–832.
https://doi.org/10.1016/j.cell.2010.01.040
- PubMed
- Google Scholar
1. Shi J
2. Gao W
3. Shao F
(2017) Pyroptosis: gasdermin-mediated programmed necrotic cell death
Trends in Biochemical Sciences 42:245–254.
https://doi.org/10.1016/j.tibs.2016.10.004
- PubMed
- Google Scholar
(2020) Type I interferon-independent T cell impairment in a tmem173 N153S/WT mouse model of sting associated vasculopathy with onset in infancy (SAVI)
Clinical Immunology 216:108466.
https://doi.org/10.1016/j.clim.2020.108466
- PubMed
- Google Scholar
1. Sliter DA
2. Martinez J
3. Hao L
4. Chen X
5. Sun N
6. Fischer TD
7. Burman JL
8. Li Y
9. Zhang Z
10. Narendra DP
11. Cai H
12. Borsche M
13. Klein C
14. Youle RJ
(2018) Parkin and pink1 mitigate sting-induced inflammation
Nature 561:258–262.
https://doi.org/10.1038/s41586-018-0448-9
- PubMed
- Google Scholar
1. Spandidos A
2. Wang X
3. Wang H
4. Seed B
(2010) PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification
Nucleic Acids Research 38:D792–D799.
https://doi.org/10.1093/nar/gkp1005
- PubMed
- Google Scholar
(2012) A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-dopa replacement in MPTP-treated mice
Neurobiology of Disease 45:591–600.
https://doi.org/10.1016/j.nbd.2011.09.017
- PubMed
- Google Scholar
(2017) Sirtuin 2 enhances dopaminergic differentiation via the Akt/GSK-3β/β-catenin pathway
Neurobiology of Aging 56:7–16.
https://doi.org/10.1016/j.neurobiolaging.2017.04.001
- PubMed
- Google Scholar
1. Szegő É.M
2. Dominguez-Meijide A
3. Gerhardt E
4. König A
5. Koss DJ
6. Li W
7. Pinho R
8. Fahlbusch C
9. Johnson M
10. Santos P
11. Villar-Piqué A
12. Thom T
13. Rizzoli S
14. Schmitz M
15. Li J
16. Zerr I
17. Attems J
18. Jahn O
19. Outeiro TF
(2019) Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies
Cell Reports 28:65–77.
https://doi.org/10.1016/j.celrep.2019.06.009
- PubMed
- Google Scholar
1. Szegő ÉM
2. Boß F
3. Komnig D
4. Gärtner C
5. Höfs L
6. Shaykhalishahi H
7. Wördehoff MM
8. Saridaki T
9. Schulz JB
10. Hoyer W
11. Falkenburger BH
(2021) A β-wrapin targeting the N-terminus of α-synuclein monomers reduces fibril-induced aggregation in neurons
Frontiers in Neuroscience 15:751.
https://doi.org/10.3389/fnins.2021.696440
- PubMed
- Google Scholar
(2022) Rab7 reduces α-synuclein toxicity in rats and primary neurons
Experimental Neurology 347:113900.
https://doi.org/10.1016/j.expneurol.2021.113900
- PubMed
- Google Scholar
(2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases
EMBO Molecular Medicine 11:10248.
https://doi.org/10.15252/emmm.201810248
- PubMed
- Google Scholar
1. Wang W
2. Hu D
3. Wu C
4. Feng Y
5. Li A
6. Liu W
7. Wang Y
8. Chen K
9. Tian M
10. Xiao F
11. Zhang Q
12. Shereen MA
13. Chen W
14. Pan P
15. Wan P
16. Wu K
17. Wu J
(2020) STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection
PLOS Pathog 16:8335.
https://doi.org/10.1371/JOURNAL.PPAT.1008335
- Google Scholar
1. Wang C
2. Fan L
3. Khawaja RR
4. Liu B
5. Zhan L
6. Kodama L
7. Chin M
8. Li Y
9. Le D
10. Zhou Y
11. Condello C
12. Grinberg LT
13. Seeley WW
14. Miller BL
15. Mok SA
16. Gestwicki JE
17. Cuervo AM
18. Luo W
19. Gan L
(2022) Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy
Nature Communications 13:1969.
https://doi.org/10.1038/s41467-022-29552-6
- PubMed
- Google Scholar
1. Warner JD
2. Irizarry-Caro RA
3. Bennion BG
4. Ai TL
5. Smith AM
6. Miner CA
7. Sakai T
8. Gonugunta VK
9. Wu J
10. Platt DJ
11. Yan N
12. Miner JJ
(2017) STING-associated vasculopathy develops independently of IRF3 in mice
The Journal of Experimental Medicine 214:3279–3292.
https://doi.org/10.1084/jem.20171351
- PubMed
- Google Scholar
1. West AP
2. Khoury-Hanold W
3. Staron M
4. Tal MC
5. Pineda CM
6. Lang SM
7. Bestwick M
8. Duguay BA
9. Raimundo N
10. MacDuff DA
11. Kaech SM
12. Smiley JR
13. Means RE
14. Iwasaki A
15. Shadel GS
(2015) Mitochondrial DNA stress primes the antiviral innate immune response
Nature 520:553–557.
https://doi.org/10.1038/nature14156
- PubMed
- Google Scholar
(2017) Microglia in physiology and disease
Annual Review of Physiology 79:619–643.
https://doi.org/10.1146/annurev-physiol-022516-034406
- PubMed
- Google Scholar
1. Wu J
2. Chen YJ
3. Dobbs N
4. Sakai T
5. Liou J
6. Miner JJ
7. Yan N
(2019) STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death
The Journal of Experimental Medicine 216:867–883.
https://doi.org/10.1084/jem.20182192
- Google Scholar
1. Xu D
2. Zhao H
3. Jin M
4. Zhu H
5. Shan B
6. Geng J
7. Dziedzic SA
8. Amin P
9. Mifflin L
10. Naito MG
11. Najafov A
12. Xing J
13. Yan L
14. Liu J
15. Qin Y
16. Hu X
17. Wang H
18. Zhang M
19. Manuel VJ
20. Tan L
21. He Z
22. Sun ZJ
23. Lee VMY
24. Wagner G
25. Yuan J
(2020) Modulating TRADD to restore cellular homeostasis and inhibit apoptosis
Nature 587:133–138.
https://doi.org/10.1038/s41586-020-2757-z
- PubMed
- Google Scholar
1. Yu CH
2. Davidson S
3. Harapas CR
4. Hilton JB
5. Mlodzianoski MJ
6. Laohamonthonkul P
7. Louis C
8. Low RRJ
9. Moecking J
10. De Nardo D
11. Balka KR
12. Calleja DJ
13. Moghaddas F
14. Ni E
15. McLean CA
16. Samson AL
17. Tyebji S
18. Tonkin CJ
19. Bye CR
20. Turner BJ
21. Pepin G
22. Gantier MP
23. Rogers KL
24. McArthur K
25. Crouch PJ
26. Masters SL
(2020) Tdp-43 triggers mitochondrial DNA release via MPTP to activate cgas/sting in ALS
Cell 183:636–649.
https://doi.org/10.1016/j.cell.2020.09.020
- PubMed
- Google Scholar
1. Yum S
2. Li M
3. Fang Y
4. Chen ZJ
(2021) Tbk1 recruitment to sting activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections
PNAS 118:e2100225118.
https://doi.org/10.1073/pnas.2100225118
- PubMed
- Google Scholar

Decision letter

Keqiang Ye

Reviewing Editor; Chinese Academy of Sciences, China
Mone Zaidi

Senior Editor; Icahn School of Medicine at Mount Sinai, United States

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

[Editors' note: this paper was reviewed by Review Commons.]

Thank you for submitting your article "Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice" for consideration by eLife. Your article has been reviewed by 3 peer reviewers at Review Commons, and the evaluation at eLife has been overseen by a Reviewing Editor and Mone Zaidi as the Senior Editor.

The revised manuscript has addressed most of the raised concerns in the previous review. Though additional data substantially strengthen the manuscript, two of the referees still remain concerned with some of the data, and they both raised some further concerns.

For instance, review #2 noted some issues with the new data in Figure 6F-I. "The authors present ASC staining to quantify ASC puncta within microglia and astroglia from striatal sections. Given Iba1+ cells have more total ASC is the increase ni ASC puncta just dut to higher overall levels i.e. if normalised for expression of ASC are there more puncta? Also an explanation for why Casp1 KO have less ASC and ASC puncta is required. Caspase1 is downstream of ASC puncta formation so why is there less ASC and ASC puncta in these KO cells?". Reviewer #2 felt that their hypothesis is largely confirmed in this revision, and support publication. But before that they should perform MAP2 staining and add some description regarding unexpected findings in Discussion. But s/he complained that "However, some points, which are within my main claims in previous submission, are not yet completely resolved. In Figure 5, pSTAT-positive cells are neurons (this is consistent with their assumption), and NF-κB positive cells also seem non-astrocyte and non-microglia. It is a little bit strange that they did not use the neuronal marker MAP2 for this analysis. They should do this, because brain is a complex tissue, and it is usually unacceptable not to dissect the pathology to cell types in a standard- or high-level journal."

If you feel that you could address these concerns, we would expect your resubmission in the near future!

https://doi.org/10.7554/eLife.81943.sa1

Author response

Reviewer #1:

1) “The authors could consider qualifying the observations as preliminary as no mechanistic data or longer-term pathophysiology is investigated. Indeed, the latter is well beyond the current scope and may require generation of cell-type specific STING ki mice.”

Thank you for the comment. We have qualified our observations as preliminary (line 662). Indeed, generating cell-type specific STING ki mice is part of our future plans.

2) The authors consistently write "NF-κB/inflammasomes" – these two pathways (although related) are quite distinct and should not be lumped together in such a way.

Thank you for this important note, we now corrected the text (for example see section headings in the Results section, lines 338 and 415).

3) Line 79: "NRLP3" should be corrected to NLRP3. Line 210: age of "adult mice" in weeks should be state in the text and figure legend.

Thank you, corrected.

4) Line 262: In Figure 3B and D the images look very different and there is no indication of what a positive inclusion is? This should be indicated on the image.

Thank you for the suggestion. We replaced the corresponding panels with new images, where we show the nuclei with blue, and the Thioflavin S staining with magenta pseudo-color (current Figure 3E). We marked the outline of Thioflavin S positive cells with yellow. An inset showing the magnification of some neurons with inclusions is also presented.

5) Line 280: The data of Ifi44 should also be mentioned in the text.

Thank you. We performed new experiments to show the gene expression changes in the striatum and in the substantia nigra, therefore majority of the gene expression data from the cortex has been moved to the supplementary material (supplemental Figures 3 and 5), and is not discussed in detailed in the current manuscript.

6) Line 290: Figure 4, Examining IL-1B and Caspase-1 transcripts is not a readout of inflammasome activation. pro-IL1B is upregulated in response to NFkB activity. Inflammasome activation is commonly examined in other methods e.g. via ASC puncta formation (imaging based), active IL-1B secretion (ELISA), Caspase-1 and IL-1B cleavage via western blot

Thank you for this suggestion, we performed new experiments and added the data as Figure 6.

1) We performed Western blot analysis to detect IL-1β cleavage and NLRP3 proteins from the striatum (Figure 6C-E). 2) We quantified the number of ASC puncta within microglia and astroglia from striatal sections (Figure 6F-I). 3). 3) We also measured the protein levels of several additional immune mediators in the striatum of STING ki and KO animals (supplemental Figure 6, summary heatmap is on Figure 7A).

7) Line 310: The NF-κB subunit examined should be stated (p65?). Furthermore, IRF3 translocation might be a better readout for STING activation.

We indeed detected the p65 subunit of NF-κB (antibody is listed in the supplemental Table), and now it is also indicated in the text (line 366).

We also performed subcellular fractionation and quantified IRF3 in the nuclear and cytoplasmic fractions. The data is now added on Figure 6A, B.

8) Discussion: Given the findings here suggest a strong role for NF-κB, a short discussion of IFN vs non-IFN responses from STING should be included. There have been a number of seminal papers demonstrating the importance of non-IFN STING responses of late as well as much evidence from SAVI mice to suggest some non-IFN driven pathologies.

Thank you for the suggestion. The data on inflammasomes were given a separate section in the results (from line 395). In the discussion, from line 535 we discuss the IFN dependent response and from line 548 we discuss the non-IFN driven pathways.

9) Discussion: Is there any evidence from the human SAVI patients of neuroinflammation etc. This should be mentioned either way in the discussion.

Thank you for this comment. The manifestation of neurological symptoms is not a core feature of the human SAVI disease. Some patients suffer from various neurological symptoms e.g. calcification of basal ganglia, spastic diplegia and episodes of seizure (Fremond et al., 2021).

We inserted a short text in discussion (lines 532-534).

10) Discussion: There is a large body of work demonstrating STING-induced cell death in numerous cell types. Despite this it is not mentioned nor discussed but should be. It could represent how dopaminergic neurons are lost in the STING ki mice.

Thank you for pointing out the gap in our discussion. We added additional text in lines 604-618.

11) The resolution/quality of some of the imaging is not great but this may be due to PDF compression

Reviewer #2:

1) The authors base their conclusions (line 215-216) on the neuroinflammatory status of their mice strongly on an assessment of the Iba1 and GFAP-positive area fraction. Increase of Iba1 and GFAP areas does not necessarily correlate with an increased cytokine production and release by the cells. Therefore, in addition the measurement of cytokine mRNAs it would be necessary to measure cytokines also on protein level (see also #4 and #5).

Thank you for this suggestion, we measured the protein levels of several immune mediators with LEGENDplex assay from the striatum, and the new data are included as Figure 7A and supplemental Figure 6.

2) In the same context: Is the increase of Iba1 and GFAP- covered area due to increased proliferation of microglia and astrocytes or due to increased expression of these markers in activated glia? How is the number of Iba1/GFAP-positive cells affected?

We quantified the number of glia cells in the striatum and in the substantia nigra of adult STING WT and STING ki mice, and, parallel with higher immunoreactivity for the corresponding markers, we detected increased number of cells as well. The quantifications are now included in supplemental Figure 1.

3) Nowadays we know that microglia and astrocytes can exist in a variety of activated states which can be either beneficial or detrimental. An analysis of disease-associated microglial markers (Keren-Shaul et al. 2017) would give a good picture of the state microglia are in.

Thank you for the suggestion. In addition to the panel of immune modulators at the protein level (supplemental Figure 6), we performed qPCR analysis of additional “M1” marker (Nos2) and additional “M2” markers (Il4, Fizz2, Ym1) (Gong et al., 2019). The data is included in Figure 7A and shown in supplemental figure 6. The findings are described from line 431.

4) It also would be of interest to determine which cell type is responsible for the observed neurodegeneration. Which cytokines are released by microglia or astrocytes upon STING activation? Even in vitro experiments would help here to get a more profound understanding.

We agree with the suggestion, however, the further in vitro experiments are beyond the scopes of this study and will be the basis of a future project.

5) In line 273 the authors describe that STING is known to activate NFkB and the inflammasome. As proof that this is also occurring in their mouse, they perform qPCR analysis of whole brain IL-1b, TNF-a and Casp1 expression. While this analysis indicates that there is indeed an increased mRNA production of proinflammatory cytokines in the brains of STING ki mice, it does not give any indication whether the inflammasome is active or not. The inflammasome is a protein complex largely regulated on protein level. Meaning an assessment of the cleavage of Caspase 1 on protein level or the presence of cleaved IL-1b in comparison to uncleaved Pro-IL-1b by Western Blot as well as a staining for the number of inflammasomes would be required to draw these conclusions.

Thank you for the suggestion. We performed additional experiments: (1) Western blot to detect pro-IL1b and IL1b and NLRP3 proteins from the striatum (Figure 6C-E), and (2) we quantified the number of ASC puncta within microglia and astroglia from striatal sections (Figure 6F-I).

6) To conclude that NFkb/inflammasome pathway is the most active/crucial in astrocytes (line 354) a staining for ASC inflammasomes would be of importance, especially as astrocytes normally do not express NLRP3.

Thank you for this comment. We stained brain sections for ASC specks and for microglia (Iba1) and astroglia (GFAP) markers (Figure 6F-I). Although amount of ASC specks in astroglia was lower than in microglia, we found still a substantial amount of ASC specks in astroglia in the brains of STING ki animals.

7) As already shown for ALS (Yu et al., 2020) and Parkin KO (Sliter et al. 2018), the authors want to further assess the relevance of the STING pathway to PD (line 27-28). Therefore, an in-depth analysis of key PD hallmarks beyond phosphorylated a-synuclein, lossthe other was parkin/PINK related (so TDP deleted) of TH-stained neurons and dopamine reduction is needed. In the discussion the authors hypothesize that autophagy (line 467) may be linked to the observed phenotype. Therefore, assessment of autophagy/mitophagy as well as mitochondrial dysfunction and mtDNA should be analysed. In the same line of thought it would be important to know if and how the observed dopamine reduction effects mouse behaviour, thus mice should be subjected to the Rotarod or pole or beam walk test.

Thank you for these suggestions. In the work by Yu et al. and Sliter et al., the STING pathway was shown to mediate neurodegeneration resulting from TDP-43 pathology and mitochondrial damage. Our work is complementary by investigating the effects of constitutive activation of STING. We have therefore focused on the signaling pathways downstream of STING. As mentioned above, the most important next step will be to separate the contributions of neuronal and glial cells by generating cell type specific STING activation. Of course, it will be interesting to see at a later time point whether STING activation feeds back. We also speculate that STING activation may also cause TDP-43 pathology. Yet, this will be part of a future study. To acknowledge that the pathology is not specific to α-synuclein, we added a short statement from line 634.

With respect to the comprehensive analysis of the PD phenotype, our work includes the classical parameters of TH neuron number, TH fiber density, dopamine concentration and synuclein pathology. With respect to mouse behavior, we note that the STING ki mice have severe inflammation in the lung, kidney and other (peripheral) organs, reduced body weight and reduced lifespan (Luksch et al., 2019; Motwani et al., 2019; Siedel et al., 2020). Motor deficits cannot be attributed to dopamine neuron degeneration and for this reason were not included (stated in the Discussion, lines 624-625). In order to expand the description of the PD phenotype we now included measurements of cytosolic reactive oxygen species, mitochondrial oxygen species and nitric oxide, which result from inflammation and are known to affect dopaminergic neurons (new Figure 8).

Reviewer #3:

1) The method for quantification of TH-positive cells is not sufficient. They just described how they stained every fifth sections but did not mention how they count. This is a critical point and they should carefully provide information more than just referring their previous paper.

Counting of dopaminergic neurons and quantification of fibers was described in a dedicated section of the methods. This section has now been expanded (from line 154).

2) It is not persuasive that they did not investigate local inflammation in SN. They presented increased microglia and astrocytes in the striatum but not analyzed these cells in SN.

Indeed, we measured neuroinflammation in the substantia nigra as well, however, although increased in STING ki mice, it was less pronounced than neuroinflammation in the striatum. We now include the quantification of area fraction as well as cell number counting of microglia and astroglia in the substantia nigra of STING WT and STING ki animals (supplemental Figure 1), and also the expression of inflammatory mediators in Figure 4.

3) In Figure 3, they analyzed α-synuclein phosphorylation and β-sheet structure in the striatum. This is funny from the aspect of Parkinson's disease, which dominantly affects SN. They should perform similar experiments with SN samples. In a different aspect, the aggregates detected by Thio S may not be α-synuclein and could be tau, TDP43 or other substances. Phospho-synuclein of course does not mean aggregation, so they can consider electron microscopy.

We agree with the reviewer. To complement our data, we therefore performed solubility assay both from the striatum and from the substantia nigra to quantify the ratio of α-synuclein in the Triton X-100 soluble and insoluble fractions (Figure 3C, D) as previously (Szego et al., 2022; Szegő et al., 2019). Additionally, we quantified phosphorylated α-synuclein from the substantia nigra as well (Figure 3A,B).

We also agree with the reviewer that the presence of Thioflavin S-positive inclusions may also contain other, β-sheet forming proteins and noted this from line 634.

4) Figure 5, pSTAT3 increased in Iba1-negative cells, which seem neurons from the size of nuclei. First, the authors should investigate the identity of pSTAT3-positive cells with GFAP and MAP2. If pSTAT3 is actually increased in neurons, what does it mean in the pathology? For instance, in viral infection, STAT3 activation triggers suicide of neurons to prevent further proliferation of viral particles in neurons. Is it homologous or other function?

Thank you for this suggestion. The brain sections were stained for Iba1 and GFAP. pSTAT3 nuclear staining indeed increased in non-glia cells, based on the morphology, we think in neurons. However, detailed characterization of the signal is out of the scopes of this (preliminary) study.

5) In Figure 6 and overall, cell types in which the activation of three signaling pathways, were mixed up and hard to understand the actual situation in the brain.

In our model, STING is activated in all cells. Consequently, we cannot determine the origin of immune mediators found elevated in the STING ki mice. This will require cell type specific STING activation. In order to react to the reviewer’s comment and be clearer, we have added more details about the brain region and age of mice used for each analysis also in the figures.

6) In the method section, the original paper for generation of heterozygous STING N153S KI mice should be Warner et al., JEM 2017.

We used a STING N153S ki mouse strain that was independently generated in the Technical University Dresden (Luksch et al., 2019).

7) NF-κB stains seem located in cytoplasm in Figure 5B.

We agree: especially in the young STING ki mice, cytoplasmic NF-κB staining is increased compared to STING WT mice. To quantify nuclear translocation, however, we counted the number of those cells where NF-κB signal was overlapping with the nuclear Hoechst staining.

8) In Figure 4 and 6, why the authors evaluate gene expressions in frontal cortex instead of SN or striatum.

As noted in several comments, we show here that the STING-induced pathology involves dopaminergic neurons, but believe that it is not specific for the dopaminergic system given that STING-ki is ubiquitously expressed. For practical reasons, we have used cortical samples for the expression analysis. For consistency, we now performed additional qPCR measurement from the striatum and from the substantia nigra and included them as new Figure 4 and supplemental Figure 6N-Q. The previous data from the cortex was moved to the supplemental Figures 3 and 5. Additionally, we measured the levels of several inflammatory modulators from the striatum of STING ki and KO animals (Figure 7A and supplemental figure 6A-M).

9) In some groups (Sting-ki;ifnar1-/- in Figure 6C, 6E), the values were separated to two groups, which makes readers to doubt on soundness of their genotyping.

Our genotyping protocol is highly standardized, and the genotype of the animals were correctly assigned. In Author response image 1 we provide an example of gel images showing the products after PCR reactions for the STING N153S allele (Author response image 1a), STING WT allele (Author response image 1b), Ifnara WT allele (Author response image 1c) and lack of Ifnara allele (Author response image 1d) of the same animals. We note that a bimodal distribution of phenotypes is often observed in Ifnar-/- mice.

Author response image 1

Download asset Open asset

Example for correct genotyping of animals used in the experiments.

(a) PCR product by using primers specifically detecting the N153S variant of STING. (b) PCR product by using primers specifically detecting the WT (mouse) variant of STING. Mice with ID 66, 69, 70 and 71 are STING ki expressing both the mutant Sting1 and the WT Sting1. Mice with ID 67, 68, 72, 73 are STING WT. (c) PCR product by using primers specifically detecting the mouse Ifnar. (d) PCR product by using primers specifically detecting the lack of mouse Ifnar. All mice are Ifnar^-/-.

[Editors' note: further revisions were suggested prior to acceptance, as described below.]

The revised manuscript has addressed most of the raised concerns in the previous review. Though additional data substantially strengthen the manuscript, two of the referees still remain concerned with some of the data, and they both raised some further concerns.

For instance, review #2 noted some issues with the new data in Figure 6F-I. "The authors present ASC staining to quantify ASC puncta within microglia and astroglia from striatal sections. Given Iba1+ cells have more total ASC is the increase ni ASC puncta just dut to higher overall levels i.e. if normalised for expression of ASC are there more puncta?

In response to this comment, we measured the mean fluorescence intensity in the ASC channel from the same images that we used for ASC puncta analysis. Indeed, the intensity of the ASC signal was higher in Iba1-positive microglia than in GFAP-positive astroglia. This difference was observed in both genotypes, but particularly pronounced in STING ki animals. The data was added as the new supplemental Figure 5J and noted in line 424ff. As hypothesized by the reviewer, the increase in ASC staining intensity correlated strongly with the increase in ASC puncta as in author response image 2.

Author response image 2

Download asset Open asset

Also an explanation for why Casp1 KO have less ASC and ASC puncta is required. Caspase1 is downstream of ASC puncta formation so why is there less ASC and ASC puncta in these KO cells?".

Inflammasomes are multiprotein complexes which are formed and activated upon recognition of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). Formation of inflammasomes results in caspase-1 activation followed by IL-1b release. Inflammasome formation in mice requires priming via NF-κB to induce expression of the scaffold protein NLRP3 (Bauernfeind et al. J Immunol 183 (2) 2009; Broz & Dixit. Nature Rev Immunol 16 (7) 2016). This priming is reduced in Casp1-/- mice due to the reduction of IL-1b cleavage and release and, hence, less NF-κB activation. In conclusion, inflammasome activation is reduced in caspase-1 deficient mice.

This background was clarified in line 431ff. of the text.

Reviewer #2 felt that their hypothesis is largely confirmed in this revision, and support publication. But before that they should perform MAP2 staining and add some description regarding unexpected findings in Discussion. But s/he complained that "However, some points, which are within my main claims in previous submission, are not yet completely resolved.

In Figure 5, pSTAT-positive cells are neurons (this is consistent with their assumption), and NF-κB positive cells also seem non-astrocyte and non-microglia. It is a little bit strange that they did not use the neuronal marker MAP2 for this analysis. They should do this, because brain is a complex tissue, and it is usually unacceptable not to dissect the pathology to cell types in a standard- or high-level journal."

This is correct. In response to the reviewer, we stained striatal sections for pSTAT3, NeuN as neuronal marker and Iba1 for microglia. Indeed, the majority (app. 85%) of the nuclear pSTAT3 signal colocalized with NeuN. Conversely, almost 70% of striatal neurons were positive for pSTAT3 in STING ki animals. The new data is included as supplemental Figure 4 and added to the results (line 377ff).

https://doi.org/10.7554/eLife.81943.sa2

Article and author information

Author details

Eva M Szego

Department of Neurology, TU Dresden, Dresden, Germany

Contribution
Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft, Validation, Visualization, Writing – review and editing, Methodology

Contributed equally with
Laura Malz

Competing interests
No competing interests declared

"This ORCID iD identifies the author of this article:" 0000-0002-2629-2131
Laura Malz

Departments of Neurology & Pediatrics, TU Dresden, Dresden, Germany

Contribution
Investigation, Writing – review and editing

Contributed equally with
Eva M Szego

Competing interests
No competing interests declared
Nadine Bernhardt

Department of Psychiatry, TU Dresden, Dresden, Germany

Contribution
Investigation, Writing – review and editing

Competing interests
No competing interests declared

"This ORCID iD identifies the author of this article:" 0000-0002-3188-8431
Angela Rösen-Wolff

Department of Pediatrics, TU Dresden, Dresden, Germany

Contribution
Conceptualization, Resources, Supervision, Funding acquisition, Validation, Methodology, Writing – original draft, Project administration

Competing interests
No competing interests declared

"This ORCID iD identifies the author of this article:" 0000-0002-9613-5879
Björn H Falkenburger
1. Department of Neurology, TU Dresden, Dresden, Germany
2. Deutsches Zentrum für Neurodegenerative Erkrankungen, Dresden, Germany
Contribution
Conceptualization, Resources, Supervision, Funding acquisition, Validation, Methodology, Writing – original draft, Project administration

For correspondence
Bjoern.Falkenburger@dzne.de

Competing interests
No competing interests declared

"This ORCID iD identifies the author of this article:" 0000-0002-2387-526X
Hella Luksch

Department of Pediatrics, TU Dresden, Dresden, Germany

Contribution
Conceptualization, Data curation, Formal analysis, Supervision, Investigation, Methodology, Writing – original draft, Project administration

Competing interests
No competing interests declared

"This ORCID iD identifies the author of this article:" 0000-0001-7070-4992

Funding

Deutsche Forschungsgemeinschaft (FA-658-3-1)

Björn H Falkenburger

Deutsche Forschungsgemeinschaft (SFB TRR237, B18)

Angela Rösen-Wolff

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We thank Min Ae Lee-Kirsch (TU Dresden) for very helpful comments on the manuscript and Andrea Kempe, Annett Böhme, Katrin Höhne and Kristin Wogan for excellent technical assistance. Funding This work was supported by the German Research Foundation (DFG) SFB TRR237, B18 and FA-658-3-1.

Ethics

All animal experiments were carried out in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC) and approved by the Landesdirektion Dresden, Germany.

Senior Editor

Mone Zaidi, Icahn School of Medicine at Mount Sinai, United States

Reviewing Editor

Keqiang Ye, Chinese Academy of Sciences, China

Publication history

Preprint posted: February 4, 2022 (view preprint)
Received: August 2, 2022
Accepted: October 31, 2022
Accepted Manuscript published: October 31, 2022 (version 1)
Version of Record published: December 20, 2022 (version 2)

Copyright

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

1,882

Page views
489

Downloads
2

Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Mendeley

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

Eva M Szego
Laura Malz
Nadine Bernhardt
Angela Rösen-Wolff
Björn H Falkenburger
Hella Luksch

(2022)

Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice

eLife 11:e81943.

https://doi.org/10.7554/eLife.81943

Categories and tags

Research organism

Mouse

Share this article

Cite this article

Constitutive STING activation induces neuroinflammation and neurodegeneration in adult mice.

Neuroinflammation without neurodegeneration in juvenile mice with constitutive STING activation.

Constitutive STING activation induces alpha-synuclein pathology and synapse loss in adult mice.

Activation of IFN and NF-κB/inflammasome related genes in the striatum and SN of STING ki mice.

Nuclear translocation of pSTAT3 and NF-κB in the striatum of 5-week-old and 20 week-old STING WT and STING ki mice.

Activation of IRF3 and NF-kB-related signalling pathways in double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.

Neuroinflammation in adult double transgenic mice with STING ki and knock-out for Ifnar1 or Caspase-1.

Oxidative stress in the striatum of double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.

Degeneration of dopaminergic neurons in double transgenic mice with STING N153S/WT ki and knock-out for Ifnar1 or Caspase-1.

Example for correct genotyping of animals used in the experiments.

Author details

Eva M Szego

Contribution

Contributed equally with

Competing interests

Laura Malz

Contribution

Contributed equally with

Competing interests

Nadine Bernhardt

Contribution

Competing interests

Angela Rösen-Wolff

Contribution

Competing interests

Björn H Falkenburger

Contribution

For correspondence

Competing interests

Hella Luksch

Contribution

Competing interests

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

Categories and tags

Research organism

Further reading